Mechanisms of KCC2 upregulation during development by Ludwig, Anastasia
43/2008 43/2008
A
N
A
STA
SIA
 LU
D
W
IG
  M
echanism
s of K
C
C
2 U
pregulation D
uring D
evelopm
ent
Mechanisms of KCC2 Upregulation 
During Development
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
ANASTASIA LUDWIG
Institute of Biotechnology 
and 
Department of Biological and Environmental Sciences
Faculty of Biosciences 
and 
Finnish Graduate School in Neuroscience
University of Helsinki
Recent Publications in this Series:
22/2008 Janne Marvola
Neutron Activation-Based Gamma Scintigraphic Imaging and Scintigraphy-Based Pharmacokinetic Modelling of 
Per Oral Controlled Release Drug Delivery
23/2008 Malin Bomberg
Archaea in the Mycorrhizosphere of Boreal Forest Trees
24/2008 Minna Väänänen
Community Pharmacies and the Needs of Mobile EU Citizens – A Study on Finns Living in Spain
25/2008 Heli Juottonen
Archaea, Bacteria, and Methane Production Along Environmental Gradients in Fens and Bogs
26/2008 Marja Savolainen
New Insights into the Amorphous State and Related Solid-State Transformations
27/2008 Wilmer Cuellar
Sweet Potato Chlorotic Stunt Virus: Studies on Viral Synergism and Suppression of RNA Silencing
28/2008 Ricardo Nunes Bastos
Functional Dissection of Alternative Secretory Pathways in the Yeast S. Cerevisiae
29/2008 Ari Rouhiainen
Roles of HMGB1 in Cells of Circulation
30/2008 Meike Römer
Investigating Physical Properties of Solid Dosage Forms During Pharmaceutical Processing. Process Analytical 
Applications of Vibrational Spectroscopy
31/2008 Inna Miroshnyk
From Molecules and Crystals to Solid Dosage Forms: Supramolecular Approach to Understanding Properties 
and Performance of Pharmaceutical Materials
32/2008 Miia Ainasoja
Secondary Metabolites in Gerbera hybrida
33/2008 Marjo Poutanen
Microbial Proteomics
34/2008 Saara Ollila
Pathogenicity, Functional Signifi cance and Clinical Phenotype of Mismatch Repair Gene MSH2 Variants Found 
in Cancer Patients
35/2008 Pekka Hoppu
Characterisation and Processing of Amorphous Binary Mixtures with Low Glass Transition Temperature
36/2008 Henrietta Grönberg
Rhizoctonia - Scots Pine Interactions: Detection, Impact on Seedling Performance and Host Defence Gene 
Response
37/2008 Anne Tammimäki
Roles of Forced Nicotine Exposure and Comt Gene Disruption in the Development of Addiction-Related 
Behavioural and Neurochemical Changes in Mice
38/2008 Jaakko Pakarinen
Impact of the Human Bacterial Environment on Mycobacteriosis and Allergy
39/2008 Peter Würtz
Aspects and Applications of Pulse Sequence Design for Solution-State Nuclear Magnetic Resonance Spectroscopy
40/2008 Tanja Lipsanen
Process Analytical Technology Approach on Fluid Bed Granulation and Drying - Identifying Critical 
Relationships and Constructing the Design Space
41/2008 Gabija Žiedaitė
DNA Packaging and Host Cell Lysis: Late Events in Bacteriophage PRD1 Infection
42/2008 Susanna Nurmi
LFA-1 Integrin β2 Chain Phosphorylation Regulates Protein Interactions and Mediates Signals in T Cells
Helsinki 2008         ISSN 1795-7079   ISBN 978-952-10-5039-8
Mechanisms of KCC2 upregulation
during development
ANASTASIA LUDWIG
Institute of Biotechnology
and
Department of Biological and Environmental Sciences
Faculty of Biosciences
and 
Finnish Graduate School in Neuroscience
University of Helsinki
ACADEMIC DISSERTATION
To be presented, with the permission of the Faculty of Biosciences of the University 
of Helsinki, for public examination in auditorium 1041 at Biocenter 2 (Viikinkaari 7, 
Helsinki), on 21st of November 2008, at 12 noon.
Helsinki 2008
Supervised by:
Docent Claudio Rivera
Institute of Biotechnology
University of Helsinki
Finland
and
Professor Kai Kaila
Department of Biological and Environmental Sciences
Faculty of Bioscience
University of Helsinki
Finland
and
Professor Mart Saarma
Institute of Biotechnology
University of Helsinki
Finland
Reviewed by:
Professor Dan Lindholm
Minerva Institute for Medical Research
Biomedicum Helsinki
University of Helsinki
Finland
and 
Professor Hans Gerd Nothwang
Carl von Ossietzky University of Oldenburg
Germany
Opponent:
Professor Eckhard Friauf
Department of Biology
University of Kaiserslautern
Germany
ISBN 978-952-10-5039-8 (paperback)
ISBN 978-952-10-5035-0 (PDF, http://ethesis.helsinki.fi )
Yliopistopaino, Helsinki 2008
“A joy that’s shared is a joy made double”
To Pavel
TABLE OF CONTENTS
TABLE OF CONTENTS
ABBREVIATIONS
ORIGINAL PUBLICATIONS
ABSTRACT
1.  REVIEW OF THE LITERATURE ......................................................................... 1
 1.1.  GABA: an overview ............................................................................................ 1 
 1.2.  GABAA receptor mediated responses .................................................................. 1
  1.2.1. GABAA reversal potential ......................................................................... 1
  1.2.2. Shunting inhibition .................................................................................... 2
  1.2.3. Spatial aspects of GABAergic signalling in pyramidal neurons ............... 2
 1.3.  Functional aspects of GABA signalling in the immature brain .......................... 3
  1.3.1. Trophic effect of GABA on immature neurons ......................................... 3
  1.3.2. GABA and spontaneous activity ............................................................... 3
 1.4.  The family of cation-cloride cotransporters: an overview .................................. 5
  1.4.1. Family members, protein structure, function and inhibitors ..................... 5
  1.4.2. Kinetic regulation and oligomerization of CCC ....................................... 6
  1.4.3. CCC expression in the CNS ...................................................................... 8
 1.5.  NKCC1 and it’s function in the nervous system ................................................. 9
 1.6.  KCC2, a neuronal-specifi c CCC ....................................................................... 10
  1.6.1.  Developmental profi le of KCC2 expression ........................................... 10 
  1.6.2.  Role of KCC2 in regulation of intracellular Cl- ......................................  11
  1.6.3.  Role of KCC2 in spine formation ........................................................... 13
  1.6.4.  Regulation of KCC2 expression and function ........................................ 14
   1.6.4.1. Regulation of developmental KCC2 increase ............................ 14 
   1.6.4.2. KCC2 regulation in injured neurons .......................................... 16 
   1.6.4.3. KCC2 regulation in GABAergic synaptic plasticity .................. 16
 1.7.  BDNF, a member of the neurotrophin family ................................................... 17 
  1.7.1.  Neurotrophins and their receptors ........................................................... 17
  1.7.2.  BDNF synthesis, processing and secretion ............................................. 18
  1.7.3.  Expression of BDNF and TrkB in the brain ............................................ 20 
  1.7.4.  TrkB signalling ........................................................................................ 22
  1.7.5.  EGR family of transcription factors ........................................................ 24
  1.7.6.  BDNF and the GABAergic system ......................................................... 25
 1.8.  Summary ........................................................................................................... 26
AIMS OF THIS STUDY ............................................................................................. 27
2.  MATERIALS AND METHODS ........................................................................... 28
 2.1.  Cell culture procedures ...................................................................................... 28
  2.1.1.  Dissociated cell culture ........................................................................... 28
  2.1.2.  Organotypic slice culture ........................................................................ 28
  2.1.3.  Pharmacological treatments of cultured cells ......................................... 29
  2.1.4.  Transfections ........................................................................................... 29
 2.2.  In vivo studies .................................................................................................... 30
  2.2.1.  Intrahippocampal injections .................................................................... 30
  2.2.2.  Kainic acid injections and seizures ......................................................... 30
 2.3.  Detection techniques ......................................................................................... 31
  2.3.1.  Immunocytochemical procedures ........................................................... 31
  2.3.2.  Immunohistochemical procedures .......................................................... 31
  2.3.3.  Western blotting ...................................................................................... 31
  2.3.4.  Semi-quantitative and quantitative RT-PCR analysis. ............................ 31
  2.3.5.  In situ hybridization ................................................................................ 32
 2.4.  Image analysis ................................................................................................... 32
  2.4.1.  Quantifi cation of immunostaining intensity in neuronal cell bodies ...... 32
  2.4.2.  Quantifi cation of immunostaining intensity in tissue sections ................ 32
  2.4.3.  Luciferase assay ...................................................................................... 34
 2.5.  Functional 86Rb fl ux assay ................................................................................. 34
 2.6.  Sequence analysis .............................................................................................. 34
3.  RESULTS AND DISCUSSION ............................................................................. 35
 3.1.  Developmental upregulation of KCC2 in neuronal cultures in 
  the absence of activity and synaptic transmission (I) ........................................ 35
  3.1.1.  Developmental increase of KCC2 in dissociated hippocampal neurons  35
  3.1.2.  Chronic blockage of activity and synaptic transmission 
   does not affect KCC2 upregulation ......................................................... 36
 3.2.  Upregulation of KCC2 expression by transcription factor Egr4 (II) ................ 36
  3.2.1.  Egr4 strongly and specifi cally activates KCC2 promoter in N2a cells ... 37
  3.2.2.  Egr4 increases KCC2 promoter activity in cultured hippocampal 
   and cortical neurons .................................................................................38
 3.3.  On the mechanism of developmental KCC2 upregulation (III) ........................ 39
  3.3.1.  BDNF increases activity of KCC2 promoter via MAPK activation 
   and Egr4 in cultured neurons .................................................................. 39
   3.3.1.1. BDNF treatment robustly increases Egr4 expression 
                in MEK/ERK dependent manner ............................................... 39
   3.3.1.2. BDNF activates KCC2 promoter via Egr4 binding site ..............40
  3.3.2. BDNF and neurturin increase KCC2 expression in 
   immature cultured neurons ...................................................................... 40
  3.3.3.  BDNF and neurturin increase KCC2 expression when injected in 
   neonatal rat hippocampus ........................................................................ 41
  3.3.4. Endogenous network activity is involved in regulation of 
   KCC2 expression in vivo ......................................................................... 42
   3.3.4.1. Tetanus toxin injections ...............................................................42
   3.3.4.2. Kainic acid injections ................................................................. 42
 3.4.  A novel N-terminal isoform of KCC2 ................................................................43
  3.4.1.  Identifi cation of a new upstream exon in the KCC2 gene ...................... 44
  3.4.2.  Characterization of KCC2a expression in nervous system ..................... 44
  3.4.3.  Functionality of KCC2a ...........................................................................45
  3.4.4.  KCC2b-defi cient mice retain KCC2a mRNA expression ....................... 45
4. CONCLUSIONS ..................................................................................................... 47
5. ACKNOWLEDGEMENTS .................................................................................... 48
6. REFERENCES ........................................................................................................ 50
ABBREVIATIONS
AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
APV (2R)-amino-5-phosphonovaleric acid
BDNF brain-derived neurotrophic factor
CaMK Ca2+-calmoduline-regulated protein kinase
CCC cation chloride cotransporter
CIP cotransporter interacting protein
CKB brain-type creatin kinase
CMV  cytomegalovirus
CNS central nervous system
CREB cAMP response element-binding protein
DAG diacylglycerol
DN-Egr4 dominant-negative early growth response 4
DRG dorsal root ganglia
E embryonic day
Egr4 early growth response 4
ERK extracellular signal-regulated protein kinase
EST expressed sequence tag
Frs-2 fi broblast growth factor receptor substrate-2
GAB2 growth factor receptor bound protein 2-associated protein 1
GABA -aminobutyric acid
GAD glutamic acid decarboxylase
GDNF glial cell line-derived neurotrophic factor
GDP giant depolarizing potential
GFP green fl uorescent protein
Grb2 growth factor receptor-bound protein 2
IP3 inositol-3-phosphate
KCC potassium chloride cotransporter
LTP long term potentiation
MAPK mitogen-activated protein kinase
MEK MAP/ERK kinase
nAChR nicotinic acetylcholine receptor
NGF nerve growth factor
NKCC sodium potassium chloride cotransporter
NMDA N-methyl-D-aspartic acid
OSR oxidative stress response 1
P postnatal day
PI3K phosphatidylinositol 3-kinase 
PKC protein kinase C
PLC phospholipase C 
PNS pereferal nervous system
PSP post-synaptic potential
Shc src homology 2 domain containing transforming protein
SOS son of sevenless guanylnucleotide exchange factor
SPAK Ste20-related praline-alanine-rich-kinase
TetTx tetanus toxin
Trk tropomyosin receptor kinase
TTX  tetrodotoxin
VGCC  voltage-gated Ca2+ channels
VIAAT visicular inhibitory amino acid transporter
ORIGINAL PUBLICATIONS
This thesis is based on the following publications herein referred to by their 
Roman numerals (I-IV), and on some unpublished results:
I. Ludwig A, Li H, Saarma M, Kaila K and Rivera C. Developmental upregulation 
of KCC2 in the absence of GABAergic and glutamatergic transmission. Eur J 
Neurosci. 2003 Dec;18(12):3199-206.
II. Uvarov P, Ludwig A, Markkanen M, Rivera C, Airaksinen MS. Upregulation of 
the neuron-specifi c K+/Cl-cotransporter expression by transcription factor early 
growth response 4. J Neurosci. 2006 Dec 27;26(52):13463-73.
III. Ludwig A, Uvarov P, Shuschmann S, Thomas-Crusells J, Saarma M, Airaksinen 
M, and Rivera C. Egr4 mediates BDNF- and Neurturin-evoked MAPK-dependent 
upregulation of KCC2 in developing neurons. Manuscript is under submission
IV. Uvarov P*, Ludwig A*, Markkanen M, Pruunsild P, Kaila K, Delpire E, Timmusk 
T, Rivera C, Airaksinen MS. A novel N-terminal isoform of the neuron-specifi c 
K-Cl cotransporter KCC2. J Biol Chem. 2007 Oct 19;282(42):30570-6. Epub 
2007 Aug 22.
 *equal contribution
ABSTRACT
Gamma-aminobutyric acid (GABA) acting through ionotropic GABAA receptors plays 
a crucial role in the activity of the central nervous system (CNS). It triggers Ca2+ rise 
providing trophic support in developing neurons and conducts fast inhibitory function 
in mature neuronal networks. There is a developmental change in the GABAA reversal 
potential towards more negative levels during the fi rst two postnatal weeks in rodent 
hippocampus. This change provides the basis for mature GABAergic activity and is 
attributable to the developmental expression of the neuron-specifi c potassium chloride 
cotransporter 2 (KCC2). 
In this work we have studied the mechanisms responsible for the control of KCC2 
developmental expression. As a model system we used hippocampal dissociated cultures 
plated from embryonic day (E) 17 mice embryos before the onset of KCC2 expression. 
We showed that KCC2 was signifi cantly up-regulated during the fi rst two weeks of culture 
development. Interestingly, the level of KCC2 upregulation was not altered by chronic 
pharmacological blockage of action potentials as well as GABAergic and glutamatergic 
synaptic transmission. 
By in silico analysis of the proximal KCC2 promoter region we identifi ed 10 
candidate transcription factor binding sites that are highly conserved in mammalian 
KCC2 genes. One of these transcription factors, namely early growth response factor 
4 (Egr4), had similar developmental profi le as KCC2 and considerably increased the 
activity of mouse KCC2 gene in neuronal cells. 
Next we investigated the involvement of neurotrophic factors in regulation of 
Egr4 and KCC2 expression. We found that in immature hippocampal cultures Egr4 and 
KCC2 levels were strongly up-regulated by brain derived neurotrophic factor (BDNF) 
and neurturin. The effect of neurotrophic factors was dependent on the activation of 
a mitogen activated protein kinase (MAPK) signal transduction pathway. Intact Egr4-
binding site in proximal KCC2 promoter was required for BDNF-induced KCC2 
transcription. In vitro data were confi rmed by several in vivo experiments where we 
detected an upregulation of KCC2 protein levels after intrahippocampal administration of 
BDNF or neurturin. Importantly, a MAPK-dependent rise in Egr4 and KCC2 expression 
levels was also observed after a period of kainic acid-induced seizure activity in neonatal 
rats suggesting that neuronal activity might be involved in Egr4-mediated regulation of 
KCC2 expression. 
Finally we demonstrated that the mammalian KCC2 gene (alias Slc12a5) generated 
two neuron-specifi c isoforms by using alternative promoters and fi rst exons. A novel 
isoform of KCC2, termed KCC2a, differed from the previously known KCC2b isoform 
by 40 unique N-terminal amino acid residues. KCC2a expression was restricted to CNS, 
remained relatively constant during postnatal development, and contributed 20–50% of 
total KCC2 mRNA expression in the neonatal mouse brainstem and spinal cord.
In summary, our data provide insight into the complex regulation of KCC2 
expression during early postnatal development. Although basal KCC2 expression seems 
to be intrinsically regulated, it can be further augmented by neurotrophic factors or by 
enhanced activity triggering MAPK phosphorylation and Egr4 induction. Additional 
KCC2a isoform, regulated by another promoter, provides basal KCC2 level in neonatal 
brainstem and spinal cord required for survival of KCC2b knockout mice.
11.1. GABA: an overview
GABA is the principal inhibitory 
neurotransmitter in the central nervous 
system. Postsynaptic inhibition mediated 
by GABA was discovered 50 years ago 
in electrophysiological experiments on 
crayfi sh neurons and muscle fi bers (Boistel 
and Fatt, 1958, Kuffl er and Edwards, 
1958) and a decade later in mammalian 
CNS (Krnjevic and Schwartz, 1967), for 
review see (Kaila, 1994, Krnjević, 2004). 
The understanding of GABA function 
in the brain was later supplemented 
by the fi nding that GABA can induce 
depolarization and trophic support of 
immature neurons (reviewed in Ben-Ari et 
al., 2007 and Farrant and Kaila, 2007). 
GABA binds to specifi c trans-
membrane receptors causing the opening 
of ion channels. There are two classes of 
GABA receptors: GABAA and GABAB. 
GABAA are ionotropic receptors permeable 
to Cl- and HCO3
- . GABAB are metabotropic 
receptors indirectly promoting the 
activation of postsynaptic K+ channels and 
deactivation of presynaptic Ca2+ channels 
at the synaptic terminal. 
 
1.2. GABAA receptor mediated 
responses
Functionally, neurotransmiter-mediated 
responses can be inhibitory (reducing 
probability of postsynaptic action potential 
generation) or excitatory (increasing this 
probability). The functional outcome of 
GABAA receptors activation strongly 
depends on the properties of a post-synaptic 
cell such as GABAA reversal potential with 
respect to the resting membrane potential 
and shunting effect of GABAA receptors 
opening, which affects the spatial and 
temporal summation of excitatory and 
inhibitory inputs.  
1.2.1. GABAA reversal potential
GABAA receptors are selectively permeable 
to Cl- and to lesser extent to HCO3
-. Thus 
GABAA reversal potential is determined 
by the distribution of Cl- and HCO3
- across 
the plasma membrane (Kaila, 1994). 
In immature neurons [Cl-]i is high 
because of active Cl- accumulation. When 
measured with gramicidin perforated 
patch recordings, GABAA reversal 
potential in these neurons is signifi cantly 
more depolarized than resting membrane 
potential and under certain conditions it is 
suffi cient to cause neuronal excitation and 
even spiking (Ben-Ari, 2002, Ben-Ari, 
2007, Gao and van den Pol, 2001, Serafi ni 
et al., 1995).  
The hallmark of the GABAergic 
system development is a shift of GABAA 
mediated responses from depolarizing to 
hyperpolarizing. This is caused by a change 
of intracellular Cl- concentration from high 
to low due to the maturation of Cl- extrusion 
(Rivera et al., 1999, Rivera et al., 2005). 
Accordantly GABAA reversal potential is 
lower in adult neurons than in young ones. 
In mature hippocampal pyramidal cells 
the estimated GABAA reversal potential 
is close to the resting membrane potential. 
The developmental shift in [Cl-]i and 
GABAA reversal potential was confi rmed 
in many CNS areas such as hippocampus, 
neocortex, cerebellum, hypothalamus and 
spinal cord (Ben-Ari et al., 2007). The 
reversal potential of Cl- permeable glycine 
receptors shows a similar age-dependent 
shift towards hyperpolarization in auditory 
brainstem (Ehrlich et al., 1999). The 
developmental shift in [Cl-]i seems to be 
a very general phenomenon with only few 
exceptions known so far: photoreceptors 
(Vu et al., 2000), horizontal retinal cells 
(Kamermans and Werblin, 1992, Perlman 
and Normann, 1990), olfactory sensory 
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2neurons (Kaneko et al., 2004), and dorsal 
suprachiasmatic nucleus (Albus et al., 
2005). The current view on the mechanisms 
of [Cl-]i regulation in development will be 
discussed in section 1.6.   
HCO3
- (bicarbonate) reversal potential 
is set at approximately -10mV and thus 
bicarbonate currents are depolarizing 
(Kaila and Voipio, 1987). HCO3
- effl ux 
through GABAA receptor channels is 
effi ciently compensated by a generation of 
bicarbonate from CO2 and H2O by carbonic 
anhydrase (Pasternack et al., 1993). 
HCO3
--mediated GABAergic responses 
appear quite late in development due to a 
delayed expression of carbonic anhydrase 
(Ruusuvuori et al., 2004). In immature 
neurons the contribution of HCO3
- 
component to a total GABAA current is so 
small that it can be neglected. Bicarbonate 
currents make a signifi cant contribution 
in mature CA1 pyramidal neurons when 
GABAA receptors are massively activated. 
Strong stimulation results in a characteristic 
biphasic GABAergic response consisting 
of a fast initial hyperpolarization, followed 
by a long strong depolarization (Kaila and 
Voipio, 1997, Smirnov et al., 1999). 
1.2.2. Shunting inhibition
Additionally to a depolarization or 
hyperpolarization of a membrane, 
simultaneous activation of many GABAA 
receptor channels lead to a rapid decrease 
in membrane resistance. This effect occurs 
at the peak of a GABAergic response and it 
is called “shunting inhibition”. Regardless 
of the direction of membrane potential 
shift, the shunting effect negatively 
attenuates simultaneous excitatory inputs. 
Depolarizing glutamatergic responses can 
be shunted during the peak and potentiated 
during the decay phase of depolarizing 
GABA-induce responses (Chen et al., 
1996). 
1.2.3. Spatial aspects of GABAergic 
signalling in pyramidal neurons
There are spatial aspects of GABAergic 
signalling that have to be taken into account 
when speaking of GABAA receptor-
mediated responses (Andersen et al., 
1980). Firstly, the majority of GABAergic 
synapses are found in somatic and proximal 
dendritic areas of mature pyramidal neurons 
in contrast to glutamatergic synapses that 
are formed mainly on dendrites. Although 
at early developmental stages GABAergic 
and glutamatergic synapses are evenly 
distributed, later they are directed to a 
separate areas of pyramidal cells in a 
process called “synaptic segregation” 
(Benson and Cohen, 1996, Marty et al., 
2002). Secondly, there is a differential 
distribution of GABAergic synapses when 
different types of interneurons project 
on a pyramidal cell. Some interneuronal 
subtypes project to the soma area whereas 
others make synapses on the initial segment 
of a pyramidal cell axon (Freund and 
Buzsaki, 1996, Somogyi, 1977). Finally, 
recent works have shown that there is a 
gradient of intracellular Cl- concentration 
along the axo-soma-dendritic axes with the 
highest Cl- level in the axon initial segment 
and the lowest in proximal dendrites 
(Khirug et al., 2008, Szabadics et al., 
2006). This gradient allows a depolarizing 
GABA response in the axon initial segment 
and hyperpolarizing in somato-dendritic 
area of the same pyramidal neuron. 
Fluctuation of GABAA reversal and 
resting membrane potentials, shunting 
inhibition, as well as spatial aspects of 
GABAergic signalling imply that the 
effect of GABA is largely dependent on 
a target. As discussed in the next section, 
the dual aspects of GABAergic signalling 
(inhibitory vs. excitatory) are especially 
interesting in relation to immature brain 
where, apart from being an inhibitory 
neurotransmitter, GABA mediates 
3depolarizing responses, promotes neuronal 
differentiation and tunes spontaneous 
activity of developing neuronal network.
   
1.3. Functional aspects of GABA 
signalling in the immature brain
1.3.1. Trophic effect of GABA on 
immature neurons
GABA depolarization has an important 
trophic infl uence on immature neurons 
(Owens and Kriegstein, 2002, Represa 
and Ben-Ari, 2005). Components of the 
GABAergic system are functional already 
at neuronal precursor stage (LoTurco et 
al., 1995) . GABAA receptors are activated 
by tonic GABA release prior to formation 
of functional synapses (Demarque et al., 
2002, Owens et al., 1999). GABAergic 
synapses are the fi rst to become functional 
and provide most of excitatory drive to 
developing neurons (Ben-Ari et al., 2004, 
Ben-Ari, 2002, Gozlan and Ben-Ari, 
2003, Hennou et al., 2002, Tyzio et al., 
1999). In immature neurons activation of 
GABAA receptors leads to action potential 
generation, opening of voltage-gated 
calcium channels and NMDA receptor 
activation (Eilers et al., 2001, Gao and van 
den Pol, 2001, Leinekugel et al., 1995, 
Obrietan and van den Pol, 1995, Serafi ni 
et al., 1995, Yuste and Katz, 1991). 
GABA-mediated [Ca2+]i increase activates 
intracellular cascades that are important in 
mediating various trophic effects from cell 
proliferation to synaptogenesis and circuit 
formation (Fiszman and Schousboe, 
2004).  In particular depolarizing GABA 
stimulates BDNF synthesis (Berninger 
et al., 1995, Marty et al., 1996) via 
MAPK- and CREB-dependent mechanism 
(Obrietan et al., 2002). 
Despite the large body of in 
vitro evidence showing that GABA 
depolarization is an important trophic 
factor in developing brain, there are only 
few in vivo studies in this area. Surprisingly, 
there are no structural alterations in early 
brain development of transgenic mice 
where GABA synthesis, vesicular transport 
or vesicular release is eliminated (Ji et al., 
1999, Varoqueaux et al., 2002, Verhage et 
al., 2000, Wojcik et al., 2006). 
However, in a recent in vivo study 
(Cancedda et al., 2007), where GABAergic 
excitation was eliminated by premature 
KCC2 expression, morphological 
maturation of KCC2 expressing neurons 
was altered while neuronal migration 
was unaffected. A selective enhancement 
of GABAergic but not glutamatergic 
synapses is observed when GABAergic 
depolarization is prematurely terminated 
in cultured neurons (Chudotvorova et 
al., 2005). The signifi cance of GABA as 
a regulator of multiple developmental 
processes is further supported by the 
exciting observations that immature 
properties of GABAergic signalling are 
recapitulated during adult neurogenesis, 
when newly-born neurons must grow and 
integrate into already established network 
(Ge et al., 2007) 
1.3.2. GABA and spontaneous activity
Another important function of depolarizing 
GABA is its role in synchronized 
spontaneous activity of immature 
neuronal network. Synchronized activity, 
generated independently of sensory 
input, is a prominent feature of many 
immature networks (Ben-Ari, 2002, Sipila 
et al., 2005). The original intracellular 
recordings of such activity were made in 
slice preparations taken from neonatal rats 
and termed “giant depolarizing potentials” 
(GDP; Ben-Ari et al., 1989). Despite the 
ongoing dispute on the mechanisms of 
GDP generation and propagation, it is 
commonly accepted that it is based on the 
interplay between GABA and glutamate 
acting on GABAA, NMDA, and AMPA 
4receptors (Ben-Ari et al., 2007, Sipilä 
and Kaila, 2008). Depolarizing GABA 
input plays an important role in GDPs 
formation as the main component of 
intracellulary recorded GDP is blocked by 
GABAA receptor antagonist (Ben-Ari et 
al., 1989). Similarly, the sodium potassium 
chloride cotransporter (NKCC1) inhibitor 
bumetanide abolishes depolarizing driving 
force for GABA and blocks GDP (Sipilä et 
al., 2006) .
Figure 1. Phylogenetic tree and proposed topologies for the members of CCC family. 
Numbers indicate degree of identity. Modifi ed from Gamba (2005).
During development, GABAergic 
responses undergo a maturation process 
that is refl ected by a shift in EGABA from 
depolarizing towards more negative values. 
It coincides with the cease of GABA-
induced Ca2+ rise and GDP termination 
(Rivera et al., 2005). The shift in EGABA 
is caused by a developmental change in 
the system controlling intracellular Cl- 
concentration, more precisely the change 
in the functionality of two cation-chloride 
cotransporters: NKCC1 and KCC2 (Fig. 2). 
NCC
NCC
51.4. The family of cation-chloride 
cotransporters: an overview
Ion transporters are integral membrane 
proteins that control cellular uptake and 
effl ux of inorganic ions. The function 
of the Na-K ATPase, a primary active 
transporter is to generate inward Na+ 
and outward K+ concentration gradient 
using the energy of ATP-hydrolysis. 
Cation-chloride cotransporters (CCC) are 
secondary active transporters that utilize 
the Na+ or K+ concentration gradients to 
move Cl- across the membrane. CCCs 
were identifi ed as important regulators of 
cellular Cl- concentration (Gamba, 2005). 
They are directly or indirectly involved 
in several crucial physiological processes 
such as cellular pH and volume regulation, 
control of the cell cycle and determining 
the polarity of neuronal responses to 
inhibitory neurotransmitters GABA and 
glycine (Payne et al., 2003).
1.4.1. Family members, protein 
structure, function and inhibitors
The CCC family consists of 9 members, 
7 of which are well-characterized and 
include one gene encoding a Na+-Cl- 
cotransporter, two genes encoding Na+-K+-
2Cl-cotransporters and  four genes encoding 
K+-Cl- cotransporters (Fig. 1; reviewed in 
Gamba, 2005 and Hebert et al., 2004). The 
functions and ion specifi city of the newest 
known CCC family members CCC9 and 
CIP (cotransporter interacting protein) 
have not been defi nitively determined yet 
(Caron et al., 2000, Gamba, 2005).
N(K)CCs, KCCs and CIP are large 
integral membrane proteins, possessing 
12 transmembrane domains fl anked 
by hydrophilic amino and carboxy 
terminal domains. The most distantly 
related member CCC9 possesses only 11 
transmembrane domains and the carboxy 
terminal domain is predicted to be located 
outside the cell.    
The molecular diversity of CCC 
members is further increased by 
alternative splicing (reviewed in Adragna 
et al., 2004 and Gamba, 2005). At least 
6 isoforms are known for NKCC2, three 
of which possess truncated carboxi-
terminal domain generated via utilization 
of an alternative polyadenylation site. Two 
isoforms of NKCC1 differ by deletion 
of 21st exon. Two alternately spliced 
isoforms are predicted for KCC1 based 
on cDNA analysis. Two KCC3 isoforms 
are generated by utilization of alternative 
promoter and alternative splicing of the 
fi rst exon and differ in their expression 
pattern. And fi nally, two KCC4 cDNAs 
are characterized; however one codes a 
short and probably non-functional protein. 
The functional signifi cance of CCC splice 
variants is poorly understood.
All characterized members of CCC 
family couple Cl- transport with cation 
movement (Na+ and K+) in a stoichiometry 
that does not generate current and changes 
in membrane potential. Because Na+ 
and K+ gradients are quickly restored by 
ion pumps, the principal result of CCC 
activation is generation of a Cl- gradient. 
CCCs are bidirectional transporters 
and can carry out ion infl ux or effl ux 
depending on the concentration gradients 
of transported ions. Under normal 
physiological conditions NKCCs ensure 
active Cl- accumulation and KCCs – Cl- 
extrusion (Fig. 2). 
Several substances were found 
to inhibit CCCs function. The Na+-
Cl- cotransporter is sensitive to the 
diuretic thiazide (Stokes, 1984) whereas 
Na+-K+-2Cl- cotransporters and  K+-Cl- 
cotransporters are sensitive to ‘loop’-type 
diuretics like furosemide and bumetanide 
(Gillen et al., 1996, O’Grady et al., 1987). 
Furosemide has about equal potency for 
both NKCCs and KCCs (Ki ~ 25-50 M) 
whereas bumetanide has a ~500-fold 
6greater affi nity for NKCCs (Ki ~ 0.1 M) 
and at low concentrations can be used as a 
specifi c inhibitor of NKCCs (Payne et al., 
2003). 
1.4.2. Kinetic regulation and 
oligomerization of CCCs
In many biochemical studies functional 
characterization of CCC members was 
obtained by exogenous expression in 
HEK293 cells or Xenopus laevis oocytes 
and subsequent 86Rb fl ux assay (Gamba et 
al., 1994, Gillen et al., 1996, Hiki et al., 
1999, Mercado et al., 2000, Mercado et 
al., 2005, Payne et al., 1995, Payne et al., 
1996, Race et al., 1999, Song et al., 2002, 
Xu et al., 1994). The functional properties 
of the transporters, e.g. affi nity constants 
of corresponding ions and inhibitors, 
activation by medium tonicity as well as 
the effect of kinase/phosphatase inhibitors 
were studied (reviewed in Gamba, 2005). 
One interesting conclusion can be made 
based on comparison of affi nity constants. 
KCC2 has the highest affi nity for K+ 
among all KCCs. In neurons where KCC2 
is expressed, under normal physiological 
conditions [K+]o is low and KCC2 mediates 
Cl- effl ux thus lowering [Cl-]i. However, 
under conditions of heavy neuronal activity 
or under pathophysiological conditions 
[K+]o is elevated. Rise in [K
+]o will result 
in reverse of KCC2 transport direction 
and reuptake of extracellular K+ at the 
expense of intracellular Cl-  accumulation 
(Jarolimek et al., 1999, Payne, 1997). 
This would intensify network activity in 
response to the K+-induced depolarization 
and also because fast hyperpolarizing 
GABAergic inhibition is based on low 
[Cl-]i in neurons.
Cotransporters display distinct kinetic 
regulation. Classical studies of Na-K-2Cl 
cotransport in non-neuronal cells showed 
that it is activated by cell shrinkage, low 
intracellular Cl-, as well as by agents that 
stimulate intracellular kinase activity 
or reduce phosphatase activity. On the 
contrary, K-Cl cotransport is stimulated 
by cell-swelling and agents that stimulate 
phosphatase activity or reduce kinase 
activity (Flatman, 2002, Lauf and 
Adragna, 2000). Kinetic regulation of 
cation-chloride cotransport is implicated 
in the control of cell volume. Following 
cell swelling, K-Cl cotransport is activated 
and mediates ion effl ux, thus decreasing 
intracellular osmolarity and accomplishing 
regulatory cell volume decrease. Following 
cell shrinkage, Na-K-2Cl cotransport is 
activated and mediates ion infl ux, thus 
increasing intracellular osmolarity and 
accomplishing regulatory cell volume 
increase. Both NKCC and KCC activation 
by tonicity of the medium require 
phosphorylation or dephosphorylation 
events respectively (Jennings and Schulz, 
1991, Lytle and Forbush, 1992). Further 
studies have revealed that [Cl-]i is involved 
in regulation of its own transport by 
affecting the cotransporters’ osmotic 
sensitivity (Gillen and Forbush, 1999, 
Lytle and McManus, 2002). 
From all K-Cl cotransporters only 
KCC2 is active under isotonic conditions 
whereas others are activated in hypotonic 
medium (Payne, 1997, Song et al., 2002; 
reviewed in Gamba, 2005). This implies 
that in contrast to others, KCC2 is 
most likely not involved in cell volume 
regulation. However, the studies of KCC2 
regulation by medium tonicity were carried 
out in non-neuronal cells and their results 
cannot be extrapolated to neurons.  
Although it is generally accepted 
that phosphorylation status affects 
cotransporter activity, for a long time the 
direct phosphorylation was demonstrated 
only for NKCC1 (Lytle and Forbush, 
1992). The exciting story of fi nding 
7residues that are phosphorylated upon 
NKCC1 activation is reviewed in Gamba 
(2005). Finally, Darman and Forbush 
(2002) identifi ed three phosphorylated 
threonine residues in N-terminal part of 
the protein (residues 184, 189 and 202 in 
shark NKCC1 sequence). Mutation of one 
of them resulted in complete inhibition of 
the cotransporter whereas mutations of 
two others altered regulation of NKCC1 
activity by [Cl-]i. 
Recently some progress was achieved 
in studies of KCC2 phosphorylation. 
There are consensus sites for both 
tyrosine and serine-threonine kinases in 
the KCC2 sequence. A canonical tyrosine 
kinase motif is located in the carboxy 
terminal domain of KCC2; the tyrosin 
in this motif is conserved among all 
KCCs. When the conserved tyrosin was 
substituted with aspartate, mimicking the 
phosphorylation event, transport activity 
of KCC2 under isotonic conditions and 
hypotonic activation were dramatically 
reduced (Strange et al., 2000). However, 
pharmacological blockade of tyrosin 
kinases had no effect on KCC2 activity in 
experiments performed in oocytes. Notably, 
the same reagents inhibit K-Cl cotransport 
in neuronal cultures (Kelsch et al., 2001). 
The consensus sites for serine-threonine 
kinases PKA and PKC are located in both 
carboxy and amino termini of KCC2. A 
recent study revealed that Ser940 is a major 
site for PKC-dependent phosphorylation 
of KCC2 (Lee et al., 2007). Importantly, 
PKC-dependent phosphorylation of Ser940 
increases KCC2 activity and enhances 
KCC2 surface stability by slowing 
endocytosis. Similar mechanisms may 
be involved in the surface stability 
changes implicated in activity-dependent 
downregulation of KCC2 in hippocampal 
slices (Rivera et al., 2004).
Several other kinases are implicated in 
kinetic regulation of CCC members based 
on their interactions with cotransporters, 
namely Ste20-related proline-alanine-rich-
kinase (SPAK), oxidative stress response 1 
(OSR1), WNK family kinases and brain-
type creatin kinase (CKB). 
SPAK and OSR1 recognition motif 
was found in NKCC1 as well as in other 
members of CCC family, except for 
KCC2, TSC and two orphan members 
(reviewed in Delpire and Gagnon, 2006). 
The interaction of the cotransporters 
with SPAK and OSR1 was shown using 
the yeast two-hybrid system (Piechotta 
et al., 2002). Cotransfection of HEK293 
cells with NKCC1 and dominant negative 
SPAK drastically reduced NKCC1 
phosphorylation and inhibited its activation 
with hypertonic medium or low Cl- (Dowd 
and Forbush, 2003). Surprisingly, mutation 
of SPAK-OSR motif completely prevented 
the interaction between NKCC1 and 
SPAK however did not alter hypertonic or 
low chloride induction of NKCC1 activity 
(Piechotta et al., 2003). This result was not 
confi rmed by subsequent studies from the 
same group, which demonstrated that SPAK 
binding is essential for NKCC1 activation 
(Gagnon et al., 2007). Investigations using 
SPAK binding domain as bait identifi ed 
WNK kinases as possible partners of 
SPAK (Piechotta et al., 2003). Recently 
WNK kinases were shown to reciprocally 
regulate the activity of KCCs and NKCCs, 
affect cotransporter sensitivity to osmotic 
changes and increase NKCC1 and NKCC2 
phosphorylation (reviewed in Kahle et al., 
2006). 
WNK and SPAK expression was 
found in the brain areas where kinetic 
regulation of NKCC1 and KCC2 activity 
was predicted. WNK3 is expressed in the 
brain in suprachiasmatic nucleus where 
circadian [Cl-]i oscillations allow opposite 
8response to GABA during day and night 
time (Shimura et al., 2002, Wagner et al., 
1997). SPAK expression was found in the 
brainstem cochlear nucleus (Piechotta 
et al., 2003) where existence of inactive 
KCC2 form was reported (Vale et al., 
2003, Vale et al., 2005)     
CKB interaction with KCC2 was 
identifi ed be the means of two-hybrid 
system using KCC2 C-terminus as bait 
and confi rmed by coimmunoprecipitation 
studies (Inoue et al., 2004). Overexpression 
of CKB activates KCC2 (Inoue et al., 
2006). Creatin kinases are involved in 
ATP regeneration, so CKB may provide 
ATP for other molecules interacting with 
KCC2.
In addition to phosphorylation, the 
transport activity of CCC members is 
infl uenced by their quaternary structure. 
Formation of hetero- and homooligomers 
has been shown for nearly all cotransporters 
(Blaesse et al., 2006, Casula et al., 2001, 
Moore-Hoon and Turner, 2000, Simard et 
al., 2007, Starremans et al., 2003, de Jong 
et al., 2003). Interestingly, coexpression of 
non-functional N-terminal truncated KCC1 
with functional full-length KCC1 leads to 
a dominant-negative effect suppressing 
wild-type KCC1 functionality (Casula et 
al., 2001). This implies that oligomerization 
is essential for KCC1 activation. Analysis 
of one of the newest members of CCC 
family, CIP, revealed that although this 
protein seems to be non-functional as 
ionic transporter, it is able to interact 
with NKCC1 and effectively suppress its 
activity (Caron et al., 2000). These data 
open the possibility of regulation of CCC 
functionality via oligomerization.
1.4.3. CCC expression in the CNS
In CNS, the CCC family is represented by 
NKCC1 and four KCCs: KCC1, KCC2, 
KCC3 and KCC4. In the original studies 
reporting cloning and characterization 
of the cotransporters, all of them except 
for KCC2 were found to be expressed in 
several tissues, including brain (Delpire et 
al., 1994, Gillen et al., 1996, Mount et al., 
1999). In contrast to others, KCC2 shows 
strictly CNS-specifi c expression pattern 
(Payne et al., 1996) and was confi rmed by 
subsequent works (Kanaka et al., 2001, 
Rivera et al., 1999, Williams et al., 1999) 
to be expressed exclusively in neurons. 
The levels and patterns of 
cotransporters expression in immature 
and adult rodent brain have been carefully 
studied (Clayton et al., 1998, Hübner et 
al., 2001, Kanaka et al., 2001, Le Rouzic 
et al., 2006, Li et al., 2002, Lu et al., 
1999, Mikawa et al., 2002, Plotkin et al., 
1997a, Plotkin et al., 1997b). Expression 
of the cotransporters seems to be strictly 
regulated in time and space. For example, 
during embryonic development KCC2 
is expressed in mature regions, KCC3 in 
newly differentiated regions, KCC4 and 
NKCC1 in undifferentiated regions (Li et 
al., 2002). 
Differential temporal and spatial 
expression patterns of CCC members in the 
brain imply distinct roles for the various 
cotransporters in neuronal development and 
function. Differences in the cotransporters’ 
amino acid sequences might result in a 
differential kinetic regulation (Mount 
et al., 1999) which makes them suitable 
for different tasks. Yet, there is no clear 
evidence of KCC1 and KCC4 function 
in the nervous system (Gamba, 2005). 
KCC3–/– mice displayed axon swelling 
and progressive neurodegeneration in 
the peripheral nervous system (PNS) and 
CNS; altered regulatory volume decrease 
in neurons, reduced neuronal [Cl-]i and 
lower seizure threshold (Boettger et al., 
2003, Byun and Delpire, 2007)
9The data concerning NKCC1 and 
KCC2 expression and function in nervous 
cells suggest that these two cotransporters 
are the major players in the regulation of 
neuronal [Cl-]i (Payne et al., 2003).
1.5. NKCC1 and its function in the 
nervous system
There are a number of thorough studies 
addressing NKCC1 mRNA and protein 
expression in developing and adult rodent 
brain. Unfortunately the results reported in 
these studies are somewhat contradictory. 
During embryonic development profound 
NKCC1 mRNA and protein levels were 
detected in the ventricular zone of the 
ganglionic eminences while moderate 
levels were found in the ventricular 
zone of neocortex, suggesting that 
NKCC1 might be involved in neuronal 
proliferation (Hübner et al., 2001, Li et al., 
2002). These data are contradictory to the 
previously published work where NKCC1 
mRNA was detected in cortical plate but 
not in ventricular zone (Clayton et al., 
1998). During postnatal development 
some studies report general decrease of 
NKCC1 mRNA and protein expression 
with neuronal maturation in forebrain and 
cerebellum (Plotkin et al., 1997b, Yamada 
et al., 2004); others show increase of 
NKCC1 mRNA and protein expression in 
developing rat brain in general (Clayton 
et al., 1998, Yan et al., 2001), and more 
specifi cally in cerebellum (Mikawa et 
al., 2002) and hippocampus (Wang et al., 
2002). 
In immature and adult brain, NKCC1 
expression is high in choroid plexus where 
the cotransporter might be involved in 
cerebrospinal fl uid secretion and volume 
regulation along with KCC1, KCC3 and 
KCC4 (Kanaka et al., 2001, Karadsheh et 
al., 2004, Le Rouzic et al., 2006, Li et al., 
2002, Plotkin et al., 1997a).  
In mature brain moderate to low 
expression of NKCC1 is detected in the 
brainstem, olfactory bulb, thalamus, 
cortex, pyramidal and granular neurons of 
hippocampus and Purkinje and granular 
neurons of cerebellum, although the data 
on expression levels and patterns are 
confl icting (Clayton et al., 1998, Kanaka et 
al., 2001, Plotkin et al., 1997a, Wang et al., 
2002). Immunohistochemistry data in the 
studies mentioned above were generated 
using two different NKCC1 antibodies: 
rabbit polyclonal (amino acids 938-1011; 
Kaplan et al., 1996) and mouse monoclonal 
(amino acids 902-1212; Lytle et al., 1995). 
Although in Western blots both antibodies 
recognize 140 kDa band corresponding 
to NKCC1, immunostainings with 
monoclonal antibody display non-specifi c 
pattern in ferret retina (Zhang et al., 2006) 
and in NKCC1 defi cient mice (Sipila et 
al., 2007, Zhang et al., 2007). Taking into 
account the confl icting results gained by 
RNA detection methods and possible non-
specifi c signal in immunohistochemical 
detection of NKCC1 protein more studies 
are needed to confi rm NKCC1 expression 
pattern in immature and adult brain.  
The function of NKCC1 has been 
studied in NKCC1 knockout animals 
(Delpire and Mount, 2002). Targeted 
disruption of NKCC1 gene revealed 
hearing loss, growth retardation, salivation 
impairment and defi cient spermatogenesis 
(Delpire et al., 1999, Evans et al., 
2000, Flagella et al., 1999, Pace et al., 
2000). However, no striking neuronal 
phenotype was found. Nevertheless, 
in neurons, as well as in other cells, 
NKCC1 is implicated in regulation of 
intracellular Cl- concentration. In DRGs 
it is responsible for Cl- accumulation and 
participates in the modulation of GABA 
neurotransmission and sensory perception 
(Sung et al., 2000). In olfactory sensory 
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neurons it maintains elevated [Cl-]i, which 
is necessary for the responsiveness to 
odour stimulation (Kaneko et al., 2004). 
NKCC1 is also involved in Cl- uptake and 
depolarizing GABA responses in immature 
neurons of the spinal cord (Delpy et al., 
2008, Rohrbough and Spitzer, 1996), 
hippocampus (Sipila et al., 2006) and 
neocortex (Achilles et al., 2007, Yamada et 
al., 2004). However, it seems that NKCC1 
is not the only protein responsible for Cl- 
accumulation in immature neurons. In 
some regions Cl- accumulation is clearly 
independent of NKCC1 expression and 
function. For instance NKCC1 is not 
detected in lateral superior olive (LSO) 
region of the brainstem although at early 
postnatal age LSO neurons have high 
[Cl-]i and depolarizing GABA response 
(Balakrishnan et al., 2003). Similarly in 
immature retinal ganglion and amacrine 
cells, deleting or blocking NKCC1 does 
not affect elevated [Cl-]i (Zhang et al., 
2007). Thus at least in retina and LSO the 
nature of inward Cl- transport system is 
not identifi ed. 
1.6. KCC2, a neuronal-specifi c CCC
In mature CNS KCC2 expression is 
abundant and strictly neuron-specifi c. A 
wide variety of brain areas were reported 
to express KCC2, including cortex, 
hippocampus, cerebellum, olfactory bulb, 
retina, brainstem and spinal cord (Kanaka 
et al., 2001, Vu et al., 2000). KCC2 is 
not detected in the PNS (Kanaka et al., 
2001, Rivera et al., 1999). An interesting 
observation is that despite broad KCC2 
expression in the CNS there is a minority 
of central neurons where KCC2 was not 
detected. These include dopaminergic 
neurons in substantia nigra (Gulacsi et 
al., 2003), and a population of neurons 
in the nucleus reticularis thalami (Bartho 
et al., 2004). On subcellular level KCC2 
is expressed in plasma membrane of 
neuronal soma and dendrites, including 
spines, but it is absent from axons (Gulyas 
et al., 2001, Li et al., 2007, Williams et al., 
1999).
 
1.6.1. Developmental profi le of KCC2 
expression
During brain development KCC2 
undergoes profound upregulation in most 
of the brain areas following neuronal 
maturation in caudal-rostral direction (Li 
et al., 2002, Stein et al., 2004, Wang et al., 
2002).  
In rat, KCC2 mRNA is detected as 
early as E12.5 in ventral horns of spinal 
cord and spreads over the rest of spinal 
cord by E18.5 (Hubner et al., 2001, Li et 
al., 2002). At E14.5 KCC2 expression is 
observed in pons, hypothalamus, basal 
ganglia and olfactory bulb (Li et al., 
2002, Stein et al., 2004). In a newborn 
rat all brain areas already express KCC2, 
except for cortex, hippocampus and 
cerebellar granule and molecular layers. 
During postnatal development KCC2 is 
strongly upregulated in the forebrain areas 
(Clayton et al., 1998, Mikawa et al., 2002, 
Rivera et al., 1999). In whole brain, from 
postnatal day (P) 1 to adult stage, KCC2 
mRNA expression is increased 7-10 times, 
protein levels are increased 4 times (Lu et 
al., 1999). 
As KCC2 expression follows the 
development of individual neurons and 
brain regions, it can be used as a marker 
of neuronal maturation (Li et al., 2002, 
Mikawa et al., 2002, Rivera et al., 1999, 
Shimizu-Okabe et al., 2002, Stein et 
al., 2004). This is also refl ected by the 
observation that steep KCC2 upregulation 
is correlated with synaptogenesis (Gulyas 
et al., 2001, Takayama and Inoue, 2006, 
Takayama and Inoue, 2007, Zhang et al., 
2006). The functional consequence of 
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this upregulation is the induction of the 
shift in GABAergic responses towards 
hyperpolarization (Rivera et al., 2005).  
1.6.2. Role of KCC2 in regulation of 
intracellular Cl-
Expressed virtually in all CNS neurons 
and isotonically active, KCC2 is the best 
candidate for the role of neuronal Cl- 
extruder (Payne et al., 1996, Payne, 1997). 
Many studies have revealed a connection 
between furosimide-sensitive K-Cl 
cotransport activity, KCC2 expression and 
changes in intracellular Cl- concentration 
(DeFazio et al., 2000, Ehrlich et al., 1999, 
Fukuda et al., 1998, Jarolimek et al., 1999, 
Kakazu et al., 1999, Shimizu-Okabe et al., 
2002, Ueno et al., 2002, Vardi et al., 2000, 
Wang et al., 2005). The developmental 
increase in functional KCC2 expression 
is considered as a main factor in the 
developmental [Cl-]i  decline and the shift 
in GABAergic/glycinergic responses 
towards hyperpolarization (Rivera et al., 
2005; Fig. 2). 
The fi rst direct evidence that KCC2 
is intimately involved in maturation of 
GABAA responses came from the study 
of developing hippocampus (Rivera et al., 
1999). In this work KCC2 expression was 
knocked-down by the means of antisense 
oligonucleotides. As a consequence, 
suppression of GABAA-mediated 
hyperpolarization was observed. Later, 
studies of KCC2 defi cient mice confi rmed 
the importance of KCC2 for hypopolarizing 
synaptic inhibition (Hubner et al., 2001, 
Woo et al., 2002). 
Transgenic mice that are fully deprived 
of KCC2 die at birth due to respiratory 
Figure 2. Regulation of intracellular Cl- by NKCC1 and KCC2. Under physiological 
conditions, in neuronal cells, Cl− uptake is mediated by NKCC1 and Cl− extrusion by KCC2. 
NKCC1- and KCC2- mediated Cl- transport is driven by Na+ and K+ concentration gradients 
generated by Na+/K+ ATPase. Modifi ed from Payne et al (2003).
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failure (Hubner et al., 2001). In spinal 
cord and brainstem of E18 homozygote 
knockout embryos motoneurons are 
strongly depolarized by GABA and 
glycine. This is accompanied by severe 
motor defects and inability to generate a 
respiratory rhythm (Hubner et al., 2001). 
Interestingly, lack of respiratory activity is 
also observed in the brainstem preparations 
from glutamic acid decarboxylase (GAD) 
65/67 double knockout mice and vesicular 
inhibitory amino acid transporter (VIAAT) 
knockout mice, the two mouse models 
with a major defi cit in GABAergic activity 
(Fujii et al., 2007). 
Another mouse model with altered 
KCC2 expression is KCC2 knockdown 
mice that retain about 5% of KCC2 levels 
(Woo et al., 2002). In a subsequent study 
these mice were shown to be specifi c 
knockout of KCC2b isoform (Uvarov 
et al., 2007). Homozygote KCC2b 
knockout pups survive after birth but are 
hyperexcitable and die within two postnatal 
weeks presumably due to repetitive seizure 
episodes. Electrophysiological recordings 
confi rmed increased excitability and 
impaired Cl- regulation in cortical and 
hippocampal neurons of these animals 
(Woo et al., 2002, Zhu et al., 2005). 
KCC2 hypomorphic mice retain 
15 – 20% of wild-type KCC2 levels 
(Tornberg et al., 2005). These animals 
display increased anxiety and seizure 
susceptibility, poor spatial learning and 
memory, hypersensitivity to thermal and 
mechanical stimuli and reduced weight, 
although they retain normal locomotor 
activity and motor coordination. The 
authors suggest that fast hyperpolarizing 
inhibition but not shunting inhibition is 
altered in KCC2 hypomorphic mice and 
that requirements for fast hyperpolarizing 
inhibition may differ among various 
functional systems of the CNS (Tornberg 
et al., 2005).   
Functional expression of KCC2 
depends on the mechanisms regulating 
KCC2 mRNA and protein synthesis, 
transport and membrane insertion of the 
protein, as well as kinetic activation of the 
cotransporter. In cortex and hippocampus 
the onset of KCC2 expression is well-
correlated with the increase in the 
effi ciency of Cl– extrusion (Clayton et al., 
1998, Rivera et al., 1999, Shimizu-Okabe 
et al., 2002). When KCC2 is exogenously 
expressed in cortical immature neurons 
it induces a substantial negative shift 
in the GABAA reversal potential (Lee 
et al., 2005). This indicates that in the 
forebrain KCC2 gene expression is rate-
limiting for the maturation of functional 
Cl- extrusion. However this is not the 
case for all brain areas. In retina, spinal 
cord and auditory brainstem in vivo (see 
below), and in developing hippocampal 
neurons in vitro (Khirug et al., 2005), the 
onset of KCC2 expression precedes its 
functional activation. It was suggested 
that in these systems regulation of KCC2 
localization, phosphorylation status and 
oligomerization, rather than KCC2 gene 
expression, is rate-limiting for functional 
Cl- extrusion.  
KCC2 expression has been detected 
in the retina of several species (Sernagor 
et al., 2003, Vardi et al., 2000, Vu et 
al., 2000). KCC2 levels are increased 
gradually during development coinciding 
with the maturation of GABAergic 
responses (Vu et al., 2000). In mature 
retina KCC2 has a differential expression 
pattern in various retinal neuronal types, 
and it is well correlated with GABAA 
reversal potential of these neurons (Vardi 
et al., 2000). However, in retinal amacrine 
and ganglion cells the gradual increase 
in KCC2 expression cannot explain the 
relatively fast shift of GABAA reversal 
potential towards more negative values. It 
was proposed that mechanisms regulating 
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KCC2 membrane integration determine 
the time of the shift in these neurons 
(Zhang et al., 2006). Interestingly, in 
some retinal neurons, like rod bipolar 
cells or starburst amacrine cells, KCC2 
is compartmentalized allowing opposite 
response to GABA within one cell 
(Gavrikov et al., 2006, Vardi et al., 2000). 
KCC2 functional expression has 
been intensively studied in the auditory 
brainstem. Maturation of auditory neurons 
is accompanied by a decrease in [Cl-]i and 
by a shift of glycinergic responses towards 
hyperpolarization during the fi rst and 
second postnatal weeks (Ehrlich et al., 
1999, Kandler and Friauf, 1995, Lohrke et 
al., 2005). Similar to forebrain regions, in 
the auditory brainstem the developmental 
decrease in [Cl-]i  is attributable to the 
increase of active Cl- extrusion (Kakazu 
et al., 1999). However, most of the KCC2 
upregulation in the brainstem occurs 
during embryonic stages (Li et al., 2002). 
KCC2 levels are similar in P3 and P12 
superior olive complex (SOC) neurons 
that are respectively depolarized or 
hyperpolarized by glycine (Balakrishnan et 
al., 2003).  Similarly, KCC2 levels do not 
change in cochlear nucleus at the period of 
glycinergic shift (Vale et al., 2005) Thus in 
the auditory brainstem the developmental 
shift in glycinergic responses seems to be 
independent of the increase in KCC2 gene 
expression, but coincides with a change 
in KCC2 phosphorylation status (Vale 
et al., 2005) and oligomerization of the 
cotransporter (Blaesse et al., 2006). 
In summary, the analysis of age-
dependent KCC2 expression has revealed 
that the developmental increase of KCC2 
expression levels is not always directly 
translated into a shift of intracellular 
Cl- concentration. In CNS regions 
where early induction of KCC2 gene 
expression precedes the time of [Cl-]i  shift, 
mechanisms regulating KCC2 localization, 
phosphorylation and oligomerization 
determine when Cl- extrusion becomes 
functional. In neocortex and hippocampus, 
KCC2 gene expression is delayed and 
coincides with the time of [Cl-]i  shift, 
implying that KCC2 is activated as soon 
as it is synthesized. It is interesting that 
KCC2 can still be functionally deactivated 
in neurons from these regions under certain 
conditions like in vitro culturing (Khirug et 
al., 2005) or intensive stimulation used for 
plasticity induction (Fiumelli and Woodin, 
2007).
1.6.3. Role of KCC2 in spine formation 
Paradoxically, KCC2 expression was 
detected in close proximity of excitatory 
synapses (Gulyas et al., 2001). Recent 
fi nding revealed a structural role of KCC2 
in spine formation (Li et al., 2007). Spine 
maturation is altered in cortical neurons of 
KCC2-defi cient mice: knockout neurons 
develop long dendritic protrusions that 
are branched and highly motile. Full- 
length KCC2 and non-functional KCC2 
mutant with N-terminal deletion, rescue 
the spine morphology of knockout 
neurons equally effi ciently; it means that 
the morphogenic role of KCC2 does not 
require its ion transporter function. Rather, 
KCC2 affects spine formation through the 
interaction of its C-terminal domain with 
the cytoskeleton-associated protein 4.1 (Li 
et al., 2007). This study points to a novel 
role of KCC2 in neuronal development: 
increase in KCC2 expression is likely to 
stimulate both glutamatergic synaptic 
transmission via spine morphogenesis and 
GABAergic hyperpolarizing inhibition via 
active Cl extrusion. Thus KCC2 might act 
as a factor that synchronizes functional 
development of excitatory and inhibitory 
neurotransmission.   
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1.6.4. Regulation of KCC2 expression 
and function
Taking into account the importance of Cl- 
homeostasis for neuronal development 
and mature neuronal network activity, it 
is not surprising that KCC2 expression 
and function are tightly regulated. Long-
term changes in chloride homeostasis 
such as developmental or chronic trauma 
conditions involve modifi cation of KCC2 
gene expression and protein synthesis. 
Short-term changes in [Cl-]i may involve 
functional activation or deactivation of the 
reserve pool of KCC2 molecules.
1.6.4.1. Regulation of developmental 
KCC2 increase 
The developmental increase in KCC2 
expression has attracted substantial 
attention in recent years. Lots of data have 
been gathered that can be roughly divided 
into three categories as discussed below. 
However, this division is artifi cial because 
all of the factors that were shown to affect 
KCC2 expression are interconnected with 
each other.  
1.6.4.1.1. GABA auto-regulation 
hypothesis
One of the fi rst studies addressing 
the regulation of KCC2 expression in 
immature cells was the work done on 
dissociated embryonic hippocampal 
neurons by Ganguly et al. (2001). During 
in vitro development these cells undergo 
both the shift in GABAergic responses 
towards hyperpolarization and the increase 
in KCC2 expression observed in vivo. In 
cultured neurons the shift of GABAergic 
responses is delayed and KCC2 expression 
is reduced when GABAA receptors are 
chronically blocked by bicuculline, 
(Ganguly et al., 2001). The effect was 
dependent on [Ca2+]i  but independent of 
neuronal spiking. This study gave rise to 
an attractive hypothesis that depolarizing 
GABA auto-regulates its developmental 
transition towards hyperpolarisation via 
[Ca2+]i  elevations. 
The GABA auto-regulation hypothesis 
was also tested in vivo, in developing 
turtle retina. Dark-rearing from hatching 
enhanced spontaneous activity and caused 
GABA to retain a depolarizing component 
(Sernagor et al., 2003). Chronic GABAA 
receptor blockade by bicuculline enhanced 
spontaneous activity and reduced KCC2 
expression (Leitch et al., 2005). 
However, subsequent in vitro and 
in vivo studies suggest that maturation 
of Cl- homeostasis may also be GABA-
independent. Chronic blockade of GABAA 
receptors in cultured neurons had no effect 
on KCC2 levels (Ludwig et al., 2003) 
or developmental change in EGABA  (Titz 
et al., 2003). Mice defi cient in VIAAT 
have a drastically reduced GABAergic 
and glycinergic synaptic transmission; 
however KCC2 induction and function in 
these animals remain intact (Wojcik et al., 
2006).
1.6.4.1.2. Synaptogenesis and neuronal 
activity 
In vivo KCC2 expression shows a 
correlation with the level of activity input 
received by neurons. It follows neuronal 
maturation, development of innervation 
and synaptogenesis (Gulyas et al., 2001, 
Takayama and Inoue, 2006, Takayama 
and Inoue, 2007, Zhang et al., 2006). 
Transient high frequency stimulation 
of the inputs induces a shift of EGABA 
towards hyperpolarization as well as 
KCC2 functional upregulation in deep 
cerebellar nucleus (Ouardouz and Sastry, 
2005). These authors provide evidence 
that cAMP-PKA pathway and protein 
synthesis are involved, although it is 
not clear whether KCC2 expression or 
function is affected.
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The developmental decrease of [Cl-]i 
and increase of KCC2 expression is 
disturbed when activity input is blocked in 
LSO by cohlear ablation before the hearing 
onset (Shibata et al., 2004). Interestingly, a 
similar disruption of Cl- regulation was 
observed with either ipsilateral ablation 
(disturbing predominantly glutamatergic 
input) or contralateral ablation (disturbing 
GABAergic/glycinergic input). This leaves 
open a question whether the pattern and 
not the activity per se is important for the 
maturation of Cl- regulatory mechanisms.  
Afferent input is essential for KCC2 
developmental upregulation in immature 
cat visual cortex (Kanold and Shatz, 
2006). The innervation of cortical layer 
4 was disrupted by means of subplate 
ablation in neonatal cats. One month after 
KCC2 expression was signifi cantly lower 
in the ablated cortex compared to non-
manipulated one, although no neuronal 
loss was observed. Surprisingly, areas 
of ablated cortex with decreased KCC2 
expression show abnormally high levels of 
BDNF. This is inconsistent with the data 
on activity-dependent BDNF expression 
(section 1.7.3), with the study of KCC2 
levels in BDNF-overexpressing mice 
(Aguado et al., 2003; section 1.6.4.1.3) 
and is rather reminiscent of trauma 
models, where BDNF increase parallels 
KCC2 downregulation (Rivera et al., 
2002, 2004).  
An interesting study was made using 
chick ciliary ganglion (CG) and dissociated 
hippocampal neurons to analyze the effect 
of nicotinic signalling on maturation of 
GABAergic responses (Liu et al., 2006). 
The chick embryo is a useful model to 
perform chronic treatments in ovo. Both 
chick CG neurons treated in ovo with 
nicotinic antagonists and hippocampal 
neurons from 7-nAChR knockout mice 
retained the excitatory GABA responses 
(Liu et al., 2006). In 7-nAChR knockout 
hippocampal neurons NKCC1 expression 
was increased and KCC2 expression was 
decreased implying that endogenous 
nicotinic cholinergic activity controls 
maturation of GABAergic signalling. 
As 7-nAChR has a relatively high Ca2+ 
permeability, this result is consistent 
with the hypothesis that Ca2+ infl ux is 
important for developmental KCC2 
upregulation. On the other hand, the most 
prominent expression of 7-nAChR in 
hippocampus is found in interneurons 
(Jones and Yakel, 1997), thus the effect 
of nicotinic cholinergic activity might be 
indirect, mediated through depolarizing 
GABAergic input.   
1.6.4.1.3. BDNF hypothesis
Neuronal activity, neurotrophin release, 
and development of GABAergic system 
are tightly interconnected in the developing 
brain (Huang et al., 1999, Marty et al., 
1997, Zhang and Poo, 2001). Consistently, 
KCC2 developmental expression is 
enhanced in BDNF-overexpressing mice 
and reduced in mice defi cient in expression 
of BDNF-receptor tropomyosin receptor 
kinase (Trk)B  (Aguado et al., 2003, 
Carmona et al., 2006). Already at E18 
KCC2 mRNA is profoundly expressed in 
BDNF-overexpressing in contrast to wild 
type hippocampi. Yet, the consequences 
of chronic BDNF-overexpression are very 
broad and at fi rst place include increase 
of GABAergic and non-GABAergic 
synaptogenesis and spontaneous correlated 
activity (Aguado et al., 2003). Thus it 
is unclear whether KCC2 expression is 
enhanced by BDNF directly, via activity-
dependent pathways or as a side-effect 
of general acceleration of neuronal 
development in the transgenic mouse.   
Despite the vast amount of data 
concerning the mechanisms involved in 
developmental KCC2 expression, a general 
hypothesis that would combine all these 
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facts is apparently absent. Intracellular 
cascades that connect extracellular signals 
such as BDNF or neuronal activity with 
KCC2 expression still remain elusive.
1.6.4.2. KCC2 regulation in injured 
neurons 
Traumatic insults to the brain are often 
accompanied by glutamate release and 
excitotoxic neuronal damage (Lipton, 
1999). Additionally, brain injury is 
followed by depolarizing GABA responses 
reminiscent of those in immature neurons 
(Payne et al., 2003). GABA-induced Ca2+ 
elevations, depolarizing EGABA shift and 
impaired Cl- extrusion were described in 
different types of neuronal trauma in vitro 
(Fukuda et al., 1998, Katchman et al., 
1994, van den Pol et al., 1996) and in vivo 
(Jin et al., 2005, Nabekura et al., 2002, 
Price et al., 2005, Toyoda et al., 2003). 
The depolarizing EGABA shift is attributable 
to acute downregulation of KCC2 
activity (Wake et al., 2007) and KCC2 
gene expression (Nabekura et al., 2002, 
Shimizu-Okabe et al., 2007, Toyoda et 
al., 2003). Importantly, impaired NKCC1 
and KCC2 expression was also found in 
surgically resected human brain specimens 
from patients with drug-resistant epilepsy 
(Huberfeld et al., 2007, Munoz et al., 2007, 
Palma et al., 2006).
Some insights in the molecular 
mechanisms of trauma-induced KCC2 
downregulation were provided by studies 
of in vitro epilepsy models. Epileptic 
activity increases expression of BDNF 
mRNA and protein (Binder et al., 2001). 
Kindling, interictal-like activity or 
exogenously applied BDNF induces TrkB 
dependent rapid downregulation of KCC2 
expression in hippocampus (Rivera et al., 
2002). BDNF-TrkB intracellular signalling 
is mediated by recruitment of the adaptor 
proteins Shc/FRS-2 and phospholipase Cγ 
(PLCγ) (Huang and Reichardt, 2003; Fig. 
4). Binding of the adaptor proteins activate 
well-known signalling cascades: Shc 
activates Ras/MAPK and phosphoinositide 
3 kinase (PI3K) pathways, PLCactivates 
the calcium/calmodulin kinase (CaMK) 
pathway (see section 1.7.4). Using 
transgenic mice with point mutations in 
either Shc/FRS-2 or PLC binding sites 
(generated by Minichiello et al. (2002)), 
it was determined that activity-dependent 
KCC2 downregulation requires both 
cascades (Rivera et al., 2004). Surprisingly, 
activation of Shc pathway alone induces 
increase in KCC2 expression, suggesting 
a role in developmental upregulation of 
KCC2. 
At fi rst glance, the rapid fall in 
KCC2 levels and consequent loss of 
hyperpolarizing inhibition cannot be 
benefi cial for neurons that are already 
damaged by trauma-induced cytotoxicity. 
However, it is known that injured adult 
neurons activate genes that are normally 
expressed at immature state (Cohen et al., 
2003). It has been suggested that neurons 
gain greater fl exibility by turning back in 
development to the state when they are 
able to regrow processes, migrate over 
lesion area, or form new contacts. It is 
likely that GABA-induced depolarization, 
known to exert trophic effects in immature 
brain, promotes survival and recovery of 
damaged neurons. 
1.6.4.3. KCC2 regulation in GABAergic 
synaptic plasticity 
It is well established that coincident fi ring 
of pre- and postsynaptic neurons induces 
potentiation of excitatory synapses. 
More recently it became obvious that 
the strength of inhibitory synapses is 
also prone to activity-induced changes 
(Dan and Poo, 2006, Gaiarsa et al., 
2002). In the hippocampus, when pre- 
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and postsynaptic cells are coincidently 
activated the strength of GABAergic 
synapses is reduced (Woodin et al., 2003). 
Repetitive postsynaptic spiking (3 Hz) 
within 20 ms before or after the activation 
of GABAergic synapses leads to a rapid 
reduction of inhibitory strength mediated 
by a local decrease in KCC2 activity in the 
postsynaptic cell and consequent positive 
shift of EGABA. Interestingly, the effect 
depends on Ca2+ infl ux and it is largely 
synapse-specifi c (Woodin et al., 2003). 
Later it was shown that repetitive 
spiking of higher frequency (10 Hz) 
alone can induce the acute Ca2+-
dependent depolarizing shift of EGABA via 
downregulation of active Cl- extrusion 
(Fiumelli et al., 2005). The shift in 
EGABA happens within minutes after the 
stimulation and thus it is attributable to 
downregulation of Cl- extrusion function 
rather than gene expression. Evidence that 
Cl- extrusion is mediated by KCC2 comes 
from the experiments where immature 
neurons are normally non-sensitive to 
repetitive spiking stimulation, but gain 
the sensitivity after being transfected 
with KCC2. The magnitude of EGABA shift 
depends on activity attaining larger values 
with higher frequency or longer duration 
of stimulation. Interestingly, the effect of 
repetitive spiking on Cl- extrusion is also 
dependent on protein kinase C (PKC) 
activation meaning that functionality of 
KCC2 in this model might be reduced by 
PKC-dependent phosphorylation (Fiumelli 
et al., 2005). Clearly, PKC-mediated 
regulation of KCC2 functionality turns out 
to be a complicated issue as in the recent 
study, Lee et al. (2007) have shown that 
PKC-dependent KCC2 phosphorylation 
enhances cell surface stability and activity 
of the cotransporter rather than reduce 
it as it was suggested by Fiumelli et al., 
(2005).  
BDNF regulates postsynaptic [Cl-]i
 
 at 
GABAergic synapses (Wardle and Poo, 
2003). Acute application of BDNF induces 
an EGABA shift towards depolarization 
mediated by rapid downregulation 
of KCC2 activity. Thus BDNF is 
suggested to participate in GABAergic 
synaptic plasticity by reducing GABA 
hyperpolarizing inhibition. Remarkably, 
this is yet another way how BDNF affects 
Cl- homeostasis and GABAergic responses 
in addition to slow developmental increase 
of KCC2 gene expression and rapid 
downregulation of KCC2 levels in injured 
neurons.   
1.7. BDNF, a member of the 
neurotrophin family
1.7.1. Neurotrophins and their 
receptors
BDNF, along with nerve growth 
factor (NGF), neurotrophin-3 (NT-3), 
neurotrophin-4/5 (NT-4/5), neurotrophin-6 
(NT-6), and neurotrophin-7 (NT-7) belong 
to the family of neurotrophic factors 
collectively called neurotrophins (Fig. 
3). Neurotrophins are structurally related, 
secreted signalling proteins that stimulate 
neuronal survival, differentiation and 
functionality (Bibel and Barde, 2000, 
Huang and Reichardt, 2001). NGF, BDNF, 
NT-3, and NT-4 are expressed in mammals 
whereas NT-6 and NT-7 are found only in 
fi sh. 
Two unrelated types of receptors were 
identifi ed for neurotrophins: high affi nity 
tropomyosin related receptor tyrosine 
kinases (Trk) and low-affi nity pan-
neurotrophin receptor p75NTR (reviewed in 
Huang and Reichardt, 2003; Fig. 3). Three 
Trk receptors bind neurotrophins with 
specifi c selectivity: NGF is a preferable 
ligand for TrkA, BDNF and NT-4 for TrkB, 
and NT-3 for TrkC. Some cross-reactivity 
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Figure 3. Neurotrophins and their 
receptors. Trk and p75NTR structural features 
such as cysteine clusters (C); leucine-rich 
repeats (LRR), immunoglobulin-like domains 
(Ig), and cysteine-repeat domains (CR) are 
depicted. Physiologically more significant 
interactions are shown in solid arrows, less 
signifi cant – in dashed arrows. Adopted from 
Reichardt (2006).
was observed between neurotrophins and 
their receptors as NT-3 can also bind to 
and activate other Trks (Barbacid, 1994, 
Davies et al., 1995). Upon ligand binding 
Trk receptors dimerize. Dimerization leads 
to the activation of the receptor tyrosine 
kinase domains, auto-phosphorylation 
and activation of intracellular signal 
transduction cascades (reviewed in Huang 
and Reichardt, 2003; see also section 
1.7.4). 
Differential splicing generates several 
TrkB isoforms with distinct functional 
properties (Huang and Reichardt, 2003). 
Among others, truncated TrkB isoforms 
lacking tyrosine kinase domain were 
described (Klein et al., 1990, Middlemas 
et al., 1991). Deletion of the tyrosine 
kinase domain eliminates tyrosine kinase 
activity of the receptor and thus abolishes 
conventional signal transduction. The 
function of truncated isoforms is not 
completely understood but collected 
evidence highlights their importance in the 
regulation of cellular response to BDNF. 
Truncated receptors were suggested 
to exert a dominant negative effect by 
inhibiting productive dimerization and 
activation of full length receptors (Eide 
et al., 1996, Ninkina et al., 1996) or by 
scavenging BDNF from the extracellular 
space (Biffo et al., 1995). 
p75NTR was characterized as pan-
neurotrophin receptor that binds all of the 
neurotrophins with similar low affi nity 
(Johnson et al., 1986, Radeke et al., 1987, 
Rodriguez-Tebar et al., 1990). p75NTR 
is a member of tumor necrosis factor 
receptor superfamily. Its intracellular 
carboxy terminal part contains a so-
called death domain that is implicated 
in the transduction of cell death signals 
(Chapman, 1995, Feinstein et al., 1995). 
p75NTR does not exhibit intrinsic catalytic 
activity and signals through association 
with cytoplasmic adaptor proteins 
(reviewed in Roux and Barker, 2002). 
Neurotrophins and their receptors 
are expressed nearly in all neuronal 
populations of the CNS and PNS and 
have well recognized roles in neuronal 
survival, process outgrowth, and synaptic 
plasticity.
1.7.2. BDNF synthesis, processing and 
secretion
BDNF is a stable dimeric protein that 
shares about 50% sequence identity with 
other neurotrophins (Radziejewski et al., 
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1992). It is produced and secreted by a 
wide variety of neuronal and nonneuronal 
cells in the PNS and CNS (Lessmann et 
al., 2003/4). BDNF is synthesized as 
prepro-BDNF that is cleaved into 32 kDa 
precursor protein, pro-BDNF. To produce 
the mature 14 kDa isoform, pro-BDNF is 
cleaved in trans-Golgi network by protease 
furin or in secretory granules by pro-protein 
convertases (Mowla, 2001, Seidah et al., 
1996). BDNF is secreted via constitutive 
pathway in non-neuronal cells and via 
both constitutive and regulated pathways 
in neurons (Seidah et al., 1996). In vitro, 
pro-BDNF is also secreted, and it accounts 
for a signifi cant proportion of a total BDNF 
that is released extracellularly (Mowla et 
al., 1999, Teng et al., 2005). Interestingly, 
recent data suggest that in CNS neurons 
do not secrete pro-BDNF (Matsumoto et 
al., 2008). Pro-BDNF is detected in brain 
tissue (Lee et al., 2001) where it has a 
similar expression pattern as the mature 
form and it is localized predominantly to 
nerve terminals (Zhou et al., 2004). This 
evidence, along with the fact that the pro-
domains of individual neurotrophins are 
highly conserved among vertebrate species 
(Suter et al., 1991), suggests that pro-
BDNF as well as other pro-neurotrophins 
may have additional biological functions. 
Indeed, Lee et al. (2001) demonstrated 
that pro-NGF binds to p75NTR receptor 
with 5-fold higher affi nity than mature 
NGF and effectively induces p75NTR-
mediated apoptosis. Similarly, Teng et al. 
(2005) showed that pro-BDNF is released 
from cultured cortical neurons and it is ten 
times more active in stimulating p75NTR-
mediated apoptosis than mature BDNF. 
Thus, in contrast to mature BDNF, pro-
BDNF interacts predominantly with p75NTR 
and exerts distinct biological effects. The 
function of pro-BDNF versus mature 
BDNF may be as opposite as mediating 
of cell death versus cell survival (Lu et 
al., 2005). Pro-BDNF may be cleaved to 
produce mature BDNF extracellularly 
by several matrix metalloproteinases 
and serine protease plasmin (Lee et al., 
2001). In this context, the regulation of 
intracellular and extracellular cleavage 
of BDNF has an important impact on its 
physiological functions. Indeed, plasmin-
mediated cleavage was shown to be an 
essential step in establishing of long-term 
hippocampal plasticity (Pang et al., 2004). 
However, it is important to stress that the 
interpretation of these results needs special 
care, as pro-BDNF secretion may be an 
experimental artifact.   
In neurons BDNF is secreted 
mainly via regulated (Ca2+-dependent) 
pathway (reviewed in Lim et al., 2003 
and Lessmann et al., 2003/4). Increase 
of [Ca2+]i is mandatory for triggering 
regulated BDNF secretion. Ca2+ may come 
from different sources. Depolarization-
induced Ca2+ fl ux from voltage-gated Ca2+ 
channels or activated NMDA receptors 
as well as Ca2+ release from endoplasmic 
reticulum were shown to be involved 
(Goodman et al., 1996, Griesbeck et al., 
1999, Marini et al., 1998, Wetmore et 
al., 1994). CaMKII acts downstream of 
Ca2+ signalling in the pathway leading to 
regulated BDNF secretion (Kolarow et 
al., 2007). Interestingly, neurotrophins can 
regulate their own secretion via activation 
of corresponding Trk receptors (Canossa 
et al., 1997, Kruttgen et al., 1998). 
Neurotrophin-dependent secretion of 
neurotrophins requires induction of PLCγ 
signalling pathways and Ca2+ release from 
intracellular Ca2+ stores (Canossa et al., 
2001). 
BDNF release at the synaptic level 
was addressed using overexpression of 
BDNF fused with fl uorescent protein GFP 
(Hartmann et al., 2001, Kojima et al., 
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2001, Kolarow et al., 2007). These studies 
demonstrated secretion of BDNF-GFP 
from post-synaptic sites at glutamatergic 
synapses and confi rmed the essential 
role of intracellular Ca2+ signalling in this 
process. Apart from post-synaptic secretion 
of BDNF-GFP, pre-synaptic secretion 
of tagged BDNF was also demonstrated. 
BDNF-GFP was anterogradely transported 
along the axon and transferred to the post-
synaptic neuron in an activity- and TrkB- 
dependent manner (Kohara et al., 2001).
Experiments with electrical 
stimulation of neurons revealed that 
patterned electrical activity induces BDNF 
secretion more effi ciently than continuous 
depolarization (Balkowiec and Katz, 2000, 
Gartner and Staiger, 2002, Lever et al., 
2001). The higher frequency stimulation 
(up to 100 Hz) induces more release of 
BDNF than the lower frequency one, and 
the most effi cient stimulation protocols are 
tetanic stimulation (bursts of 100 pulses at 
100 Hz) as well as theta burst stimulation 
(trains of 25 bursts, each burst of 4 pulses 
at 100 Hz) (Balkowiec and Katz, 2002). 
Remarkably, the two most effi cient 
stimulation protocols are associated with 
induction of synaptic plasticity: tetanic 
stimulation is often used for induction 
of long term potentiation (LTP) whereas 
theta burst stimulation is aimed to mimic 
the typical fi ring pattern of hippocampal 
neurons during learning. In line with 
the previous studies, Ca2+ infl ux through 
voltage-gated Ca2+ channels (VGCC) and 
Ca2+ release from intracellular Ca2+ stores 
are both required for the induction of 
BDNF release by electrical stimulation, 
and this induction can occur in the 
absence of glutamatergic synaptic activity 
(Balkowiec and Katz, 2002). 
Secretion of BDNF in an activity-
dependent manner plays a vital role in 
synaptic plasticity. The importance of 
activity-regulated BDNF secretion was 
highlighted by a fi nding that human 
subjects with valine (val) to methionine 
(met) substitution in pro-region of BDNF 
gene exhibit impaired hippocampal 
activity and memory function whereas in 
vitro assay demonstrated that regulated 
secretion of met-BDNF was markedly 
reduced as compared with val-BDNF 
(Chen et al., 2004, Egan, 2003).
   
1.7.3. Expression of BDNF and TrkB in 
the brain
Detailed studies have been performed 
to identify expression pattern of BDNF 
and TrkB in immature and adult brain 
using either in situ hybridization or 
immunodetection (Conner et al., 1997, 
Ernfors et al., 1990, Ernfors et al., 1992, 
Friedman et al., 1991, Friedman et al., 
1998, Fryer et al., 1996, Hofer et al., 1990, 
Ivanova and Beyer, 2001, Klein, 1990, 
Kokaia et al., 1993, Maisonpierre et al., 
1990, Schmidt-Kastner et al., 1996, Yan et 
al., 1997). 
In rodents, BDNF and TrkB expression 
starts at early embryonic stages and 
gradually increases during development 
(Ivanova and Beyer, 2001, Klein, 1990, 
Maisonpierre et al., 1990). Expression 
of the full length TrkB isoform reaches 
adult levels around birth. Interestingly, 
expression of the truncated TrkB isoform 
lacking tyrosine-kinase domain is also 
developmentally increased. Truncated 
TrkB levels stabilize at two weeks 
after birth and thereafter this isoform 
predominates over full-length TrkB (Fryer 
et al., 1996). 
Of all neurotrophins BDNF has 
the most widespread expression in the 
developing and mature nervous system. 
Similarly to BDNF, its receptor TrkB has 
an extensive expression pattern (Klein, 
1990).  BDNF and TrkB are coexpressed 
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in the same neurons in many neuronal 
populations, highlighting the importance of 
paracrine and autocrine BDNF signalling 
(Kokaia et al., 1993). For example, in the 
PNS BDNF and TrkB are prominently 
expressed in a subpopulation of dorsal 
root ganglia (DRG) neurons (Ernfors 
and Persson, 1991, Ernfors et al., 1990, 
Mu, 1993, Wright, 1995) and BDNF was 
suggested to be an autocrine survival factor 
for these neurons (Acheson et al., 1995). 
BDNF is also prominently expressed in 
inner ear sensory epithelium and supports 
in a paracrine manner survival of inner 
ear sensory neurons (Pirvola et al., 1992). 
In the CNS, the highest level of BDNF is 
observed in hippocampus and neocortex 
where it is coexpressed with TrkB (Hofer 
et al., 1990, Kokaia et al., 1993, Schmidt-
Kastner et al., 1996). In this area, locally 
released BDNF is important not only 
for promoting neuronal survival and 
differentiation but also for mediating 
synaptic plasticity in the hippocampal and 
cortical circuits (Bramham and Messaoudi, 
2005). Apart from its local effect, BDNF 
that is synthesised in hippocampal neurons 
may have a target-derived trophic function, 
as it was shown to promote survival and 
differentiation of neurons, that innervate 
this area: basal forebrain cholinergic 
neurons and locus coeruleus noradrenergic 
neurons (Alderson et al., 1990, Arenas 
and Persson, 1994, Friedman et al., 1993, 
Knusel et al., 1991). 
Within hippocampus BDNF mRNA 
and protein levels are higher in the 
dentate gyrus and CA3 than in the CA1 
subfi eld, and no BDNF mRNA is detected 
in stratum oriens (Conner et al., 1997). 
Interestingly, BDNF mRNA is detected 
only in pyramidal and granular cells but 
not found in hippocampal interneurons 
(Rocamora et al., 1996a, Schmidt-Kastner 
et al., 1996). However, interneurons 
express TrkB receptors implying that 
although they do not synthesize BDNF, 
they might be regulated in paracrine 
manner by BDNF released from pyramidal 
neurons. Indeed, BDNF was shown to 
promote differentiation of hippocampal 
and cortical GABAergic neurons (Marty 
et al., 1997; also see section 1.7.6). 
BDNF protein was found not only in 
neuronal cell bodies but also in nerve fi bers 
and nerve terminals (Conner et al., 1997, 
Friedman et al., 1998, Yan et al., 1997). 
Analysis of BDNF immunoreactivity 
provided the fi rst evidence of anterograde 
BDNF transport from distal neuronal cell 
bodies along their axons towards axonal 
terminals (Altar, 1997, Conner et al., 
1997, Smith, 1997). Anterograde transport 
of BDNF was confi rmed by experiments 
where inhibition of axonal transport or 
selective afferent elimination depletes 
BDNF immunoreactivity in corresponding 
nerve terminals (Altar, 1997, Conner et 
al., 1997). Remarkably, DRG neurons 
were the fi rst model where anterograde 
transport of a neurotrophin was directly 
observed. BDNF was shown to accumulate 
proximally to the ligation site of the sciatic 
nerve or to the crush site of the dorsal 
roots, implying that it is anterogradely 
transported from DRG neurons in both 
peripheral and central directions (Tonra et 
al., 1998, Zhou and Rush, 1996).
BDNF expression is regulated by a 
large variety of stimuli in physiological 
and pathological conditions (Lindholm 
et al., 1994). BDNF gene is controlled by 
cAMP response element-binding protein 
(CREB) and thus BDNF expression is 
activated by Ca2+ infl ux and neuronal 
activity (Ghosh et al., 1994, Shieh et al., 
1998, Tao et al., 1998, Timmusk et al., 
1993, Zafra et al., 1992). BDNF mRNA 
synthesis can be induced by convulsant 
agents like kainic acid, muscarinic 
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receptor agonist pilocarpine, as well as 
GABAA receptors antagonist bicuculline 
(Dugichdjordjevic et al., 1992, Lindholm 
et al., 1994, Wetmore et al., 1994, Zafra et 
al., 1990, da Penha Berzaghi et al., 1993). 
On the contrary, GABAA receptor agonist 
muscimol and the positive allosteric 
modulator diazepam substantially reduce 
BDNF synthesis (Zafra et al., 1991). In 
contrast to mature hippocampal neurons, at 
early postnatal age GABA is depolarizing 
and it is able to induce BDNF expression 
via MAPK/CREB-dependent mechanism 
(Berninger et al., 1995, Marty et al., 1996, 
Obrietan et al., 2002). 
BDNF expression is infl uenced by 
physiological activity in vivo. Synthesis 
of BDNF mRNA is regulated by visual 
stimuli in visual cortex of both immature 
and adult rats (Castren et al., 1992) 
and increased in the barrel cortex after 
whisker stimulation in mice (Rocamora 
et al., 1996b). Surgical transection of 
septal cholinergic afferents result in a 
reduction of BDNF levels in developing 
and adult rat hippocampus demonstrating 
that endogenous cholinergic innervation 
tonically control BDNF synthesis in this 
area (Lapchak et al., 1993, Lindefors et al., 
1992, da Penha Berzaghi et al., 1993).
Similarly to BDNF, expression, 
traffi cking and membrane insertion 
of TrkB receptors is also regulated by 
neuronal activity (reviewed in Nagappan 
and Lu, 2005). For example, LTP-inducing 
tetanic stimulation signifi cantly increases 
TrkB mRNA levels and the number of 
surface TrkB receptors (Dragunow et al., 
1997, Du et al., 2000). Activity-dependent 
modulation of TrkB receptors provides a 
basis for selective potentiation of active 
synapses by BDNF. 
1.7.4. TrkB signalling
BDNF binding to TrkB triggers 
dimerization and autophosphorylation 
of the receptor. Upon TrkB activation, 
a number of tyrosine residues are 
phosphorylated in its intracellular part. 
Some of these residues serve as docking 
sites for several adapter proteins and 
enzymes. TrkB autophosphorylation 
leads to the activation of the three major 
signalling pathways involving  MAPK, 
PI3K and PLC (reviewed in Reichardt, 
2006; Fig. 4). 
Phosphorylated tyrosine residue 
Y816 (in mouse TrkB sequence) serves 
as a direct docking site for PLCPLC 
activation mediates generation of inositol 
trisphosphate (IP3) and diacylglycerol 
(DAG), mobilization of Ca2+ stores, as well 
as activation of Ca2+ and DAG-dependent 
protein kinases, such as PKC and CaMK. 
Adaptor protein Shc binds to 
phosphorylated Y515 (in mouse TrkB 
sequence) of TrkB and it results in the 
activation of small GTPase Ras and 
subsequent transient induction of the 
extracellular signal-regulated protein 
kinase (Erk)1/2 cascade. In this pathway 
Raf is activated downstream of Ras and 
it leads to phosphorylation of MAP/ERK 
kinase (MEK)1 and/or MEK2 which in 
turn phosphorylate Erk1 and Erk2. Apart 
from Ras-dependent transient MAPK 
activation, Trk receptors may also induce 
sustained MAPK phosphorylation, 
mediated through a distinct pathway 
(Marshall, 1995; reviewed in Arevalo and 
Wu, 2006 and Huang and Reichardt, 2003). 
Sustained MAPK activation requires 
recruitment of adapter proteins Frs-2 and 
Crk, internalization of Trk receptor into 
endosomal compartment and activation of 
small GTPase Rap1 (Kouhara et al., 1997, 
Wu et al., 2001, York et al., 2000). Frs-2 
competes with Shc for the Y515 binding 
on Trk receptor and this competition is 
likely to discriminate between proliferation 
(promoted by transient MAPK activation) 
and differentiation (promoted by sustained 
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Figure 4. TrkB signaling. MAPK, PI3K, and PLCpathways are depicted. Modifi ed from 
Reichardt (2006).
MAPK activation) in PC12 cells (Meakin 
et al., 1999). 
The physiological function of PLC- 
and Shc-mediated signalling have been 
tested in vivo by mutating of PLC or 
Shc binding site in TrkB (Minichiello et 
al., 1998, Minichiello et al., 2002). These 
transgenic mice have a rather modest 
phenotype in terms of BDNF-dependent 
neuronal survival and differentiation, 
especially when compared with transgenic 
mice lacking TrkB tyrosine kinase domain 
that exhibit prominent loss of sensory 
neurons (Luikart et al., 2003). This implies 
that signaling cascades other than mediated 
by PLC, Frs-2 and Shc plays an important 
role in survival-promoting TrkB function. 
Analysis of mice with double mutation in 
both Shc and PLC binding sites revealed 
delayed migration of cortical neurons as 
well as alterations in neuronal and glia 
differentiation (Medina et al., 2004). 
Remarkably, mice with mutation 
of PLC binding site demonstrate 
TrkB
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defi ciencies in induction of both the early 
and late phases of LTP, probably due to 
the strongly reduced phosphorylation of 
CaM kinases and CREB (Minichiello 
et al., 2002). Mice with mutation of Shc 
binding site exhibit normal LTP induction 
(Minichiello et al., 1998), despite the fact 
that MAP kinases have a well established 
role in LTP formation (Adams and Sweatt, 
2002). Both transient and sustained MAPK 
activation is greatly reduced in these 
animals; however it is not fully inhibited 
even in the double Shc/PLC mutants 
(Medina et al., 2004). Crosstalk between 
PLC and Shc pathways as well as MAPK 
activation through distinct, unidentifi ed 
mechanisms may explain LTP induction in 
mice with impaired Shc binding. 
Neurons retrogradely transport 
neurotrophins released by their 
innervation targets (DiStefano et al., 
1992). The mechanism of the retrograde 
transport implies that Trk receptors are 
internalized upon ligand binding and 
transported together with the ligand in 
vesicles towards the neuronal cell body 
(Watson et al., 1999). Internalization and 
transport of Trks bring activated receptors 
into close proximity of nucleus where 
Trk signalling is required to mediate 
specifi c cellular response, such as gene 
transcription (reviewed in Heerssen and 
Segal, 2002).  Endocytosis also promotes 
transfer of activated Trk receptors to 
different membrane compartments and it 
may control the effi ciency and duration of 
Trk-mediated signalling, in part because 
many signalling components are localized 
to specifi c membrane compartments (York 
et al., 2000). Experimental acceleration 
or inhibition of ligated Trk internalization 
prevents normal cellular responses to 
these complexes (Saragovi et al., 1998, 
Zhang et al., 2000).  Endocytosis of Trks 
was shown to regulate prolonged versus 
transient ERK1/2 phosphorylation as well 
as specifi c activation of ERK5 signalling 
pathway (reviewed in Arevalo and Wu, 
2006, Heerssen and Segal, 2002, and 
Reichardt, 2006).
In addition to the activation of the 
classical signalling cascades, BDNF bind-
ing to TrkB may cause rapid (within the 
millisecond range) membrane depolari-
zation of neurons from different brain 
regions (Kafi tz et al., 1999). The authors 
suggested that depolarization was caused 
by a rapid opening of Na+ channels trig-
gered by a direct or indirect interaction of 
TrkB with the channel. Subsequent study 
revealed that tetrodotoxin-insensitive so-
dium channel NaV1.9 underlies the neu-
rotrophin-evoked excitation (Blum et al., 
2002)
1.7.5. EGR family of transcription 
factors
Neurotrophic factors promote long term 
effects via activation of gene transcription. 
Transcription of immediate early genes is 
induced rapidly and transiently in response 
to neurotrophic factor stimulation and 
does not require de novo protein synthesis. 
Many of immediate early genes are the last 
step in signal transduction cascades and 
encode transcription factors that mediate 
neurotrophins-induced gene expression 
(reviewed in Herdegen and Leah, 1998). 
Activation of MAPK induces 
transcription of a variety of immediate 
early genes, such as c-fos, c-jun and 
early growth response genes (Segal and 
Greenberg, 1996). The family of early 
growth response (Egr) genes encode 
structurally related zinc fi nger transcription 
factors and includes four members: 
Egr1-4. At least two of Egrs, Egr1 and 
Egr4, are dramatically upregulated by 
NGF in neurons and PC12 cells and thus 
are alternatively termed NGF-induced 
transcription factors (NGFIA and NGFIC 
respectively). In the nervous system 
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expression of Ergs is increased by stress, 
trauma as well as by physiological and 
pathological neuronal activity including 
seizures, LTP induction and sensory 
stimulation (Beckmann and Wilce, 1997, 
O’Donovan et al., 1999). 
Egr1 is the best studied member 
of Erg family and it is implicated in 
neuronal plasticity, learning and memory 
formation (reviewed in Davis et al., 2003 
ans Knapska and Kaczmarek, 2004). 
Expression of Egr1 and Egr2 is induced by 
TrkB-mediated BDNF signalling (Calella 
et al., 2007, Minichiello et al., 2002) and 
it is strongly impaired in mice with PLC 
docking site mutation. Egr1 expression is 
also regulated by MAP kinases in NGF-
stimulated PC12 cells and BDNF-treated 
cerebellar granular neurons (Harada et al., 
2001, Kumahara et al., 1999).
Another member of Egr family, 
Egr4, was cloned by Crosby et al. (1991). 
Unlike other Erg genes that are widely 
expressed outside of the nervous system, 
Egr4 expression is restricted to the CNS 
where it is increased during development 
(Crosby et al., 1992). Egr4 levels are 
strongly and transiently induced in PC-12 
cells by NGF, in adult rat somatosensory 
cortex by whisker stimulation and in adult 
rat cortex and hippocampus after seizures 
(Crosby et al., 1992, Honkaniemi and 
Sharp, 1999, Mack et al., 1995). Although 
Egr4 expression is sensitive to NGF 
(Crosby et al., 1991), BDNF-induced Egr4 
upregulation has not been demonstrated 
yet.  
1.7.6. BDNF and the GABAergic 
system
BDNF signalling is of outstanding 
importance in developing and adult 
nervous system. In addition to classical 
neurotrophic survival-promoting effects, 
it plays an essential role in neuronal 
differentiation and function (Lewin and 
Barde, 1996). BDNF supports development 
and maintenance of cortical circuitry 
by regulation of synapse formation, 
stabilization and strength (Aguado et al., 
2003, Vicario-Abejon et al., 1998). It is 
involved in activity-dependent synaptic 
plasticity and LTP formation (McAllister 
et al., 1999). BDNF levels are upregulated 
following injury and it has a well 
recognised neuroprotective effect (Hofer 
and Barde, 1988). 
BDNF is intimately involved in the 
development of the GABAergic system. 
In the hippocampus, BDNF is synthesised 
and secreted in the activity-dependent 
manner by pyramidal neurons and affects 
local TrkB-expressing interneurons (see 
section 1.7.3). In their in vitro study, 
Marty et al. (1996) demonstrated BDNF-
mediated regulation of interneuronal 
phenotype in immature hippocampal 
slice cultures. Later, BDNF was shown to 
induce an enlargement of the interneuronal 
somata, expression of GABAA receptor 
subunits and GABA-synthesising enzyme 
GAD65/67 as well as formation of 
GABAergic synapses (Vicario-Abejon et 
al., 1998, Yamada et al., 2002). 
Interestingly, in immature neurons 
depolarizing GABA induces BDNF 
expression (Obrietan et al., 2002) and 
through BDNF-mediated mechanism 
affects hippocampal interneurons (Marty et 
al., 1996). So, early in development GABA 
and BDNF seems to be interconnected by 
a feed-back loop mechanism with GABA 
enhancing BDNF production and BDNF 
supporting the development of GABAergic 
neurons. Remarkably, during maturation 
of GABAergic hyperpolarization, GABA 
switches from enhancing to repressing 
BDNF expression (Berninger et al., 1995) 
and thus the BDNF/GABA feed-back loop 
ceases to exist in mature neurons.
The model of BDNF/GABA 
regulation was later confi rmed by in vivo 
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studies of transgenic mice expressing 
BDNF in the nervous system earlier in 
development and at higher levels than 
wild type mice. The transgenic mice 
exhibit enhanced correlated spontaneous 
activity as well as dramatic increase 
in GABAergic synaptogenesis and 
GAD65/67 expression (Aguado et al., 
2003).  Interestingly, KCC2 levels in the 
hippocampus of BDNF overexpressing 
mice were strongly increased.  KCC2 
upregulation ensures that the feed-back 
loop between depolarizing GABA and 
BDNF will be eventually terminated by 
the decrease in [Cl–]i and the shift of EGABA 
towards more negative values.  
Apart from the regulation of 
GABAergic synaptogenesis (Marty et 
al., 2000), BDNF is also implicated in 
the modulation of GABAergic synaptic 
strength. In immature neurons BDNF 
induces a rapid and reversible potentiation 
of GABAA receptor-mediated responses 
(Mizoguchi et al., 2003). The increase 
in GABAergic responses was dependent 
on TrkB activation, PLC-induced 
[Ca2+]i rise and CAMKII.  However, during 
development BDNF effect is reversed as 
BDNF was shown to reduce GABAergic 
spontaneous activity and evoked responses 
in older hippocampal neurons (Tanaka 
et al., 1997). The GABAergic response 
reduction may be mediated via rapid 
downregulation of GABAA receptor surface 
expression (Brunig et al., 2001, Cheng 
and Yeh, 2003) and/or downregulation of 
KCC2 expression and function (Rivera et 
al., 2002, Wardle and Poo, 2003) in the 
postsynaptic cell. 
BDNF-mediated maturation of 
GABAergic inhibition has a dramatic 
effect on visual cortex development. In 
the visual cortex of transgenic mice with 
genetically enhanced BDNF expression 
the maturation of cortical interneurons 
as well as GABAergic innervation and 
inhibition is accelerated (Huang et al., 
1999). Enhanced development of cortical 
inhibitory circuit is accompanied by the 
precocious developmental decline of 
LTP formation in the visual cortex and 
premature termination of critical period 
for ocular dominance plasticity. 
1.8. Summary
The reviewed experimental data suggest 
that developmental KCC2 upregulation 
serves not only maturation of GABAergic 
inhibition, but it is also a hallmark 
of the general maturation of GABA/
BDNF/activity signaling highlighted 
by the appearance of hyperpolarizing 
GABA responses, cessation of immature 
spontaneous network activity and closure 
of critical periods for synaptic plasticity. 
With this in mind, we aimed to investigate 
the factors that regulate developmental 
increase of KCC2 expression, which is 
crucial in the transition of the hippocampal 
neuronal circuitry from immature to the 
adult stage. 
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AIMS OF THIS STUDY
The aim of this work was to study the mechanisms controlling KCC2 upregulation 
during early postnatal development of rodent hippocampus.
The specifi c aims were:
1. To test the effect of chronic activity blockade on KCC2 expression in immature 
cultured hippocampal neurons.
2. To determine what transcription factors might be involved in developmental KCC2 
expression. 
3. To investigate whether neurotrophic factors regulate KCC2 developmental 
expression and what intracellular cascades are involved. 
4. To investigate the existence of KCC2 splice variants.
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The methods used are described in detail in 
the “Materials and Methods” section of the 
respective publications. All experimental 
procedures using laboratory animals were 
performed according to ethical guidelines 
approved by local authorities.
2.1. Cell culture procedures
For studies of KCC2 developmental 
expression, mouse dissociated and 
organotypic slice cultures were used. 
Both systems provide a very useful tool 
to study neuronal development in vitro. 
However there are some differences 
between these two models that have to 
be taken into consideration. Neurons 
in dissociated cultures provide an easy 
access for pharmacological treatments 
and visualization after immunostainings. 
However cells in such cultures lack some 
essential factors guiding their maturation. 
The levels of cell-cell interactions, synaptic 
density and spontaneous activity are lower 
compared to in vivo, thus development 
of dissociated neurons might be delayed 
or disturbed. Organotypic slice cultures 
preserve the local neuronal circuit much 
better, but cells in such culture require 
time to recover after damage caused by 
cutting procedure. They are less accessible 
for drug application and microscopic 
visualization. Additionally, in our hands, 
dissociated neurons survive better than 
organotypic slices in long-term cultures 
usually employed for developmental 
studies.  
In publications II and IV two 
immortalized cell lines were used in 
addition to primary neurons. Mouse 
neuroblastoma neuro-2a (N2a) cells, 
which express a low level of KCC2 and 
no Egr4 (unpublished observations), were 
used to study transcriptional activity of 
2. MATERIALS AND METHODS
KCC2 intact or mutated promoter, and for 
Egr4 binding studies. Human embryonic 
kidney HEK293 cells were used for 86Rb-
fl ux assay. Both cell lines were cultured in 
DMEM medium supplemented with 10% 
fetal calf serum, penicillin 100 units/mL 
and streptomycin 100 μg/mL. 
2.1.1. Dissociated cell culture
Dissociated neurons were prepared from 
E17 embryonic hippocampi or cortex 
and plated either on glass coverslips or 
directly on plastic bottom of the tissue 
culture plate. The surface in both cases 
was pretreated with polyornithyne to 
improve neuronal adhesion. Only defi ned 
Neurobasal medium with serum-free B27 
suppliment (Gibco) was used. No serum, 
antibiotics or L-glutamine was added to 
neuronal cultures at any stage. To improve 
neuronal survival, before contact with 
neurons, the medium was preincubated 
overnight on the monolayer of glia cells. 
Glia cell cultures were prepared from E17 
mouse hippocampi (Banker and Goslin, 
1998) and kept during 3-4 months in 
DMEM medium supplemented with 10% 
fetal calf serum, penicillin 100 units/mL 
and streptomycin 100 μg/mL.
The density of neuronal cultures varied 
from 5×103 cells/cm2 to 5×105 cells/cm2; 
depending on the experiment. When low-
density cultures were plated (publication 
I), coverslips with neurons were kept in 
dishes containing glia monolayer for extra 
trophic support. 
2.1.2. Organotypic slice culture
Organotypic slice cultures were prepared 
from hippocampi of P0 mouse pups. 
Hippocampi were dissected; transverse 
350 m slices were cut and immediately 
placed on sterile Millicell-CM membranes 
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(Millipore, Bedford, MA, USA) in 6-well 
culture trays with 1 ml of plating medium. 
The plating medium was Neurobasal me-
dium containing B27 supplement (Gibco, 
Life Technologies), penicillin 100 units/ml 
and streptomycin 100 μg/ml. 24 hours af-
ter plating the medium was changed to the 
growth medium Neurobasal/B27 without 
antibiotics. 
2.1.3. Pharmacological treatments of 
cultured cells
Neuronal cultures were treated with 
blockers of action potential generation and 
synaptic transmission, blockers of kinases 
involved in signalling cascades as well as 
neurotrophic factors (Table 1).  
Activity blockers were added 
daily from frozen stocks prepared at 
500–1000-fold the fi nal concentration. 
Before addition, drugs were diluted to the 
fi nal concentration in the fresh medium 
preincubated for 24 h with glial culture. 
Neurotrophic factors and signalling 
cascade blockers were added once in a 
fresh glia-conditioned medium and no 
Drug Function Final concentration Used in
Tetrodotoxin (TTX) Blocks action potentials by 
binding to voltage-gated 
sodium channels
10 μm
1 M IIII
APV Selective NMDA receptor 
antagonist
40 μm I
NBQX AMPA receptor antagonist 10 μm I
Picrotoxin (PTX) GABAA receptor antagonist 50 μm I
BDNF Neurotrophic factor 10-100 ng/ml; 100 ng per 
intrahippocampal injection
III
Neurturine Neurotrophic factor 10-100 ng/ml; 1 g per 
intrahippocampal injection
III
U0126 Blocker of mitogen-activated 
protein kinase kinase (MEK)
20 M III
K252A Blocker of tyrosine kinase 
receptors
200 nM III
Kainic acid Agonist of kainate receptors 2 mg/kg (ip injections) III
SL327 MEK blocker, brain penetrant 100 mg/kg (ip injections) III
Tetanus toxin (TeTx) Blocker of synaptic release 5ng per intrahippocampal 
injection
III
medium change was performed until the 
time of analysis (5 minutes – 3 days later). 
If a signalling cascade blocker was used 
together with a neurotrophic factor, then 
the blocker was added 30 min before the 
neurotrophic factor. 
2.1.4. Transfections
 HEK293 cells, N2a cells and dissociated 
neurons were transfected with luciferase 
reporter constructs or KCC2a and KCC2b 
expression constructs using lipofectamine 
2000 (Invitrogen) according to the 
manufacturer’s protocol. The constructs 
list is presented in Table 2. To avoid 
cytotoxicity, relatively low amounts of the 
expression plasmids were used (0.5 μg per 
1-cm-diameter well). In case of HEK293 
cells and N2a cells the antibiotic-free 
medium was applied before transfection. 
In case of dissociated neurons the medium 
was completely changed 4 hours after 
transfection to improve cell survival. 
Transfection effi ciency was 30-50% in 
HEK293 cells, 15% in N2a cells and 
5-10% in dissociated neurons. 
Table 1. List of drugs used for cell culture treatment and in vivo administration
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2.2. In vivo studies
2.2.1. Intrahippocampal injections
To study the effect of neurotrophic factors 
and activity blockade on KCC2 expression 
in vivo we performed injections of the drugs 
in hippocampus of P5-P6 rat. Before the 
injection rat pups were hypothermically 
anesthetised and the head was fi xed in a 
surgical mask to maintain the skull stable. 
The stereotactic coordinates for injection 
were: anteroposterior -1.8 mm (relative to 
the bregma); mediolateral 2 mm (relative 
to the bregma); dorsoventral -2 mm from 
the cortical surface.  The injection site was 
located in CA1 area of dorsal hippocampus. 
The certain amount of BDNF, neurturin 
or TeTx (as indicated in table 1) was 
dissolved in 4l of standard ACSF 
solution and injected in hippocampus at 
~1l/min. In case of TeTx administration 
both sides were injected with the drug. In 
case of neurotrophic factor administration, 
the drug was injected only in the right-
Construct Description Used in
KCC2(–1398/+5445) A luciferase reporter that includes 1398 bp of the 
upstream regulatory region, exon-1, intron-1, and part of 
exon-2 of the mouse KCC2 gene.
II
KCC2(–1398/+42) A luciferase reporter that includes 1398 bp of an 
upstream regulatory region as well as 42 bp of the 5’-
untranslated region (5’-UTR) of the mouse KCC2 gene.
II
KCC2(–309/+42) A luciferase reporter that includes 309 bp of an upstream 
regulatory region as well as 42 bp of the 5’-untranslated 
region (5’-UTR) of the mouse KCC2 gene.
II, III
KCC2(–309/+42)Egr4mut A luciferase reporter that is similar to KCC2(–309/+42) 
but two critical dG nucleotides are replaced with two dTs 
in the Egr4 binding consensus sequence.
II, III
KCC2(–180/+42) A luciferase reporter that includes 180 bp of an upstream 
regulatory region as well as 42 bp of the 5’-untranslated 
region (5’-UTR) of the mouse KCC2 gene. It does not 
contain Egr4 binding consensus sequence.
II
Egr1 Egr1 expression vector, CMV promoter. II
Egr4 Egr4 expression vector, CMV promoter. II
DN-Egr4 An expression vector that contains the C-terminal part 
and all three zinc fi ngers, but not the N-terminal part of 
Egr4, CMV promoter.
II
side hippocampus and the left-side 
hippocampus was injected with 4 l of 
saline solution. After injection procedure 
the rat was allowed to fully recover in a 
warm chamber before being placed back 
with littermates.  
2.2.2. Kainic acid injections and 
seizures
To study the effect of enhanced 
neuronal activity in vivo we performed 
intraperitoneal injections of kainic acid 
(KA), the agonist of kainate receptors. 
KA is well-know for its ability to induce 
seizures in adult rats. We used a low dose 
of KA (2 mg/kg) which was still enough 
to induce seizures in P5 rats. There were 
virtually no lethality among injected pups 
during seizures and 1 day after.    
Within 15 minutes after KA injection 
all rats developed the fi rst sings of specifi c 
seizure behavior such as scratching, 
rapidly followed by lost of posture control 
and periods of lying on one side in tonic 
Table 2. List of constructs used for transfections
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position. One hour after KA injection, 
the seizure was ceased by intraperitoneal 
injection of paraldehyde (0.3 l/g). 
Paraldehyde was also administrated to 
control rats.
In order to study MAPK involvement 
in activity-dependent regulation of KCC2 
transcription, MEK blocker SL327 was 
administrated by intraperitoneal injection 
30 minutes before KA (Table 1).  
2.3. Detection techniques
2.3.1. Immunocytochemical 
procedures
The protocol used for immunodetection of 
antigens in dissociated neurons is described 
in details in the original articles (I, II and 
IV). List of the antibodies is provided in 
Table 3. 
2.3.2. Immunohistochemical 
procedures
The protocol used for immunodetection of 
antigens in fi xed tissue sections is described 
Primary antibody Host Source/Reference Dilution Method Used in
KCC2 Rb polyclonal (Williams et al., 1999) 1:500 ICC I
KCC2 Rb polyclonal (Ludwig et al., 2003) 1:5000 ICC
IHC
WB
I, II, III
MAP2 Mo monoclonal Chemicon 1:1000 ICC I
synaptophysin Mo monoclonal Boeringer 1:1000 ICC I
β-tubulin (βIII) Rb polyclonal BabCO, Berkeley, CA
BioSite, Sweden
1:10000 WB I, II, III
Egr4 Rb polyclonal (Zipfel et al., 1997) 1:300 WB II
pERK 1/2 Mo monoclonal Santa Cruz 
Biotechnology, USA
1:500
1:1000
ICC
WB
III
ERK 1/2 Rb polyclonal Santa Cruz 
Biotechnology, USA
1:1000 WB III
pAKT Rb polyclonal Cell Signalling 
Technology, USA
1:1000 WB III
AKT Rb polyclonal Cell Signalling 
Technology, USA
1:1000 WB III
in details in (III). After immunostaining 
sections were visualized with Leica TCS 
SP2 AOBS confocal system. List of the 
antibodies is provided in Table 3. 
2.3.3. Western blotting
The protocol used for western blotting 
protein detection is described in details in 
the original articles (I, II, and III). In study 
I X-ray fi lms were used for visualization 
of the chemifl uorescent signal, developed 
with ECL-plus (Amersham, Pharmacia 
Biotech). In later studies Luminescent 
image analyzer LAS-3000 (Fujifi lm) was 
used for the same purpose.
2.3.4.  Semi-quantitative and 
quantitative RT-PCR analysis.
The protocols used for total RNA isolation 
and RT-PCR analysis of mRNA expression 
are described in the original publications 
(II, III and IV). Primers used for RT-PCR 
were designed manually, and contained, 
when possible, intronic sequence in 
between (Table 4). For quantitative RT-
Table 3. Primary antibody used in immunochemistry and Western blotting
WB – western blotting; ICC – immunocytochemistry; IHC – immunohistochemistry 
Rb – rabbit; Mo – mouse
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PCR the cDNA samples were amplifi ed 
in triplicates using the SYBR Green PCR 
Master Mix (Applied Biosystems, Foster 
City, CA, USA) and detected via the ABI 
Prism 7000 Sequence Detection System 
(Applied Biosystems). 
2.3.5. In situ hybridization
In situ hybridization on paraffi n-embedded 
sections was done as described (Li et 
al., 2002). Sagittal sections (thickness 7 
μm) were hybridized using 35S-labelled 
antisense and sense (control) cRNA 
probes: Ret-specifi c probe (nucleotides 
2595–3191, X67812), GFR1 specifi c 
probe (nucleotides 294-1039, U59486) 
and GFR2 (full-length, AF003825) 
(Kokaia et al., 1999). No labeling above 
background was observed in the sense 
controls.
2.4. Image analysis
2.4.1. Quantifi cation of 
immunostaining intensity in neuronal 
cell bodies
For KCC2 intensity measurements in 
studies I and II, images were obtained 
with wide-fi eld fl uorescent microscope 
(Olympus AX70). On the images of MAP2 
immunostaining MAP2-positive cells were 
randomly chosen and neuronal cell bodies 
were manually outlined. Intensity of KCC2 
signal was measured in corresponding 
neurons on grey-scale images of KCC2 
immunostaining using Image-Pro Plus 
for Windows (version 4.1.0.0; Media 
Cybernetics L.P.). In wide-fi eld fl uorescent 
images the background level is substantial 
and may vary between the coverslips. To 
determine the background level, three 
neuron-free areas were manually outlined 
on each picture. The mean intensity of 
background areas was subtracted from the 
mean intensity of the neurons from the 
same coverslip.
2.4.2. Quantifi cation of immuno-
staining intensity in tissue sections
Intensity measurements of KCC2 
immunoreactivity were used to analyze 
KCC2 expression in BDNF- and neurturin- 
injected hippocampi (study III). This 
method was chosen in place of RT- PCR or 
western blot because it allowed us to see 
the spatial distribution of KCC2 expression 
levels. Due to diffusion gradient of the 
injected neurotrophic factor and because 
in vitro KCC2 expression was dependent 
on the neurotrophic factor concentration, 
an uneven change in KCC2 expression 
levels was expected.   
For each injected brain a series of 
coronal hippocampal sections was made 
at P8-P9, three days after the injection. 
The sections in the series were numbered 
in succession starting from the most 
frontal part of hippocampus.  Each section 
contained growth factor injected side 
(right) as well as control side (left).  KCC2 
levels were analyzed by immunostaining 
in sections #45, 90, 132, 177, 222 and 273. 
The section thickness was 7M which 
gives a sample interval of 315m. In each 
brain analyzed the injection site (defi ned 
by a scar) was found between section #60 
and section #90 and located in right and left 
hemisphere in CA1 area of hippocampus. 
Confocal images of immunostained tissue 
were made. For each image 9 consecutive 
optical slices (1.3 m) were made and 
merged for quantifi cation of KCC2 signal 
intensity. The region of interest was 
manually highlighted and total intensity of 
immunostaining in the region was divided 
by its area.  Then the KCC2 intensity in 
growth factor injected hemisphere was 
normalized to the KCC2 intensity in 
corresponding area of the same section 
control hemisphere. 
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Primer Sequence Location
KCC2 sense
F1a* (KCC2a-frw) 5’-GCCGGCTCCCGAGGGAAG-3’ exon-1a
F1a-2 5’-CCCGAGGGAAGACGTCAAAG-3’ exon-1a
F1a-3 5’-CGCGCCATGAGCCGCAGGTTCAC-3’ exon-1a
F1b* (KCC2b-frw) 5’-GCCACCATGCTCAACAACCT-3’ exon-1b
F1b-2 5’-TTCTTCCTCCGTGGAGCGGAG-3’ exon-1b
KCC2 antisense
R1a 5’-CTTTGACGTCTTCCCTCGGGAG-3’ exon-1a
R1a-2 5’-GGCAGCGAGGTGACCGTGAAC-3’ exon-1a
R1b 5’-CCGTCAGGTTGTTGAGCATGGTGGC-3’ exon-1b
R1b-2 5’- GCGCCGGGCTCGGGAT-3’ exon-1b
R2 5’-CTTCTCCGTGTCCGTGCTGTTGATG-3’ exon-2
R2-2* (KCC2-rev) 5’-TGAAGGGACTGCTCTCTTTGG-3’ exon-2
R3 5’-GTAGGTTGGTGTAGTTGG-3’ exon-3
R4 5’-GCAGAAGGACTCCATGATGCCTGCG-3’ exon-4
R7 5’-TCAGCATGGCGGCCGCCTCCCCACTG-3’ exon-7
R26 5’-CGCCTCGCCACCTTTATTGC-3’ 3’UTR
R26-2 5’-GGGTCTTATGTAAACGGTGACAGCG-3’ 3’UTR
GAPDH
GAPDH-fwd* 5’-TGCACCACCAACTGCTTAGC-3’ exon-4
GAPDH-rev* 5’-TGGCATGGACTGTGGTCATG-3’ exon-5
Egr4
Egr4-fwd* 5’-TCTCTCCAAGCCCACCGAAG-3’ exon-1
Egr4-rev* 5’-AACCGCCTGGATGAAGAAGC-3’ exon-2
TrkB
TrkB-fwd 5’-TCAAGTTGGCGAGACATT-3’ exon-12
TrkB-rev 5’-ATGTACTCAAAGACCATGATGAG-3’ exon-15
BDNF
BDNF-fwd* 5’-GGCCCAACGAAGAAAACCAT-3’ last exon
BDNF-rev* 5’-GCACTTGACTGCTGAGCATCA-3’ last exon
Ret
Ret-fwd 5’-ATGAAAGGGTACTGACCATGG-3’ exon-14
Ret-rev 5’-AGGACCACACATCACTTTGAG-3’ exon-16
GFRα2
GFRa2-fwd 5’-TATTGGAGCATCCATCTGGG-3’ exon-2
GFRa2-rev 5’-AGCAGTTGGGCTTCTCCTTG-3’ exon-4
5’RACE
AP1 5’-CCATCCTAATACGACTCACTATAGGGC-3’ adapter
AP2 5’-ACTCACTATAGGGCTCGAGCGGC-3 adapter
Table 4. List of primers used for RT-PCR quantifi cation and 5’RACE
Primers used in quantitative real-time PCR are marked with an asterisk
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2.4.3. Luciferase assay
Luciferase assay was used to study 
transcriptional activity of different 
KCC2 gene regulatory regions. For 
this purpose reporter constructs were 
generated bearing fi refl y luciferase gene 
under control of the promoter of interest. 
Cells were cotransfected with a fi refl y 
construct and a basic renila construct. 
Renila signal was used for normalization 
of transfection effi ciency. Two days after 
transfection cells were lysed in Passive 
Lysis Buffer (Promega). Renila and fi refl y 
luciferase activities were measured with a 
Dual-Luciferase Reporter Assay System 
according to the manufacturer’s protocol.
2.5. Functional 86Rb fl ux assay
86Rb fl ux assay was used to determine 
the functionality of the novel KCC2a 
isoform in study IV. HEK 293 cells were 
chosen for this assay because they exhibit 
high transfection effi ciency and support 
K-Cl cotransport activity of exogenously 
expressed KCC2 (Payne, 1997). The cells 
were transiently transfected with KCC2a 
and KCC2b expression plasmids. The 86Rb 
fl ux assay protocol is described in details 
in study IV and in Payne (1997). 2 μCi/
ml of 86RbCl (Amersham Biosciences) 
was used. 86Rb infl ux in the presence or 
absence of 2 mM furosemide was analyzed 
by scintillation counting (Wallac 1450 
Microbeta; PerkinElmer). 
2.6. Sequence analysis
Sequence analysis is described in details in 
original publications (II and IV). Mouse, 
rat, human, and chimpanzee KCC2 
genomic sequences, corresponding to a 1.4 
kb sequence upstream of the transcription 
start site as well as a proximal part of intron-
1, were aligned by the ClustalW program 
(Chenna et al., 2003). Putative TF binding 
sites within this region were identifi ed by 
using MatInspector software. CpG islands 
inside the KCC2 gene were analyzed using 
the CpG Plot tool. Phosphorylation patterns 
were predicted with Scansite (Obenauer et 
al., 2003).
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3. RESULTS AND DISCUSSION
3.1. Developmental upregulation of 
KCC2 in neuronal cultures in the 
absence of activity and synaptic 
transmission (I)
Many lines of evidence support the idea 
that KCC2 expression correlates with 
synaptogenesis. KCC2 is not expressed 
in cell lines of neuronal or glia origin but 
it is expressed in neurons (Payne et al., 
1996, Williams et al., 1999). KCC2 is 
absent from immature neurons devoid of 
synapses (Li et al., 2002). In cortex and 
cerebellum the developmental onset of 
KCC2 expression occurs when a neuron 
has completed migration and has settled at 
its fi nal position (Li et al., 2002, Shimizu-
Okabe et al., 2002, Takayama and Inoue, 
2006, Takayama and Inoue, 2007). The 
level of synaptic activity correlates with 
the amount of synaptic contacts received 
by a neuron. So we aimed to explore 
(1) whether in dissociated hippocampal 
cultures KCC2 expression correlates with 
synaptogenesis and (2) whether KCC2 
developmental increase requires synaptic 
activity. 
3.1.1. Developmental increase of KCC2 
in dissociated hippocampal neurons
Dissociated cultures were plated from 
hippocampi of E17 mouse embryos. At 
this embryonic stage virtually no KCC2 
expression is found in hippocampus (Li 
et al., 2002). We observed earliest KCC2 
immunoreactivity after 3 days in vitro 
(div). As the culture developed KCC2 
expression gradually increased. At early 
stages distal dendrites (indicated by 
MAP2 immunoreactivity) were devoid of 
KCC2. KCC2 expression started in cell 
bodies and spread to dendrites later (Fig. 
2 in I). Upregulation of KCC2 levels in 
dissociated cultures coincided with abrupt 
increase in synapse number as indicated 
by double immunostaining of developing 
neurons with KCC2 and synaptophysin 
antibody (Fig. 4 in I). The temporal pattern 
of KCC2 expression in dissociated neurons 
is in good agreement with in vivo data and 
confi rms the relevance of this model for 
studying developmental expression of 
KCC2. 
However the spatial distribution of 
KCC2 at early stages seems to be different 
in vitro and in vivo. In our cultures KCC2 
signal was fi rst observed in neuronal cell 
bodies whereas immunogold labeling of 
P2 and P4 hippocampal sections revealed 
early KCC2 signal in plasma membrane 
and transport vesicles of distal dendrites 
(Gulyas et al., 2001). It is plausible that 
the regulation of KCC2 transport requires 
factors defi cient in young cultured neurons, 
where posttranslational activation of 
KCC2 might be altered (Lee et al., 2007). 
Consistent with nonfunctional stage of 
KCC2 in immature hippocampal cultures, 
application of the broad-spectrum kinase 
inhibitor staurosporine produced a rapid 
KCC2 activation in cultured neurons, but 
not in neonatal acute slices (Khirug et al., 
2005) 
We also analyzed KCC2 increase in 
organotypic slice cultures prepared from 
hippocampi of P0 mouse pups. In these 
cultures KCC2 upregulation was stronger 
than in dissociated neurons (in dissociated 
cultures: from div4 to div15 – 5 fold; in 
organotypic slices: from div3 to div14 – 
10 fold; Fig. 3 in I). In organotypic slices 
neuronal connections are preserved better 
and consequently synaptic density is higher 
which might explain the stronger KCC2 
upregulation. It is also possible that in 
organotypic slices neurons develop faster 
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and represent more mature developmental 
stage compared to dissociated neurons.
3.1.2. Chronic blockage of activity and 
synaptic transmission does not affect 
KCC2 upregulation 
Neurons grown in vitro develop synaptic 
contacts and are spontaneously active 
(Banker and Goslin, 1998). To investigate 
the effect of neuronal activity on KCC2 
expression, we grew dissociated and 
organotypic cultures during two weeks 
in the presence of activity blockers (table 
1). The blockers were applied in various 
combinations daily starting from the fi rst 
day after plating. Tetrodotoxin (TTX) 
was used to block action potentials, and 
picrotoxin (PTX) was used to inhibit 
GABAergic signalling. PTX was used 
with TTX because it may cause elevated 
activity due to insuffi cient inhibition. 
AMPA and NMDA receptor antagonists 
NBQX and APV were used to block 
glutamate receptor activity. Surprisingly, 
none of the combinations, including 
the one where all the antagonists were 
added together, prevented or signifi cantly 
altered developmental KCC2 increase 
(Fig. 5 in I). Apparently, synaptic activity 
also does not contribute signifi cantly to 
the difference between KCC2 levels in 
dissociated and organotypic cultures. It 
suggests that whatever controls the scale 
of age-dependent KCC2 increase in vitro, 
it is not synaptic activity. Our results are in 
striking confl ict with Ganguly et al. (2001) 
study, where KCC2 mRNA levels were 
decreased by 70% when hippocampal 
neurons were grown for 14 days in the 
presence of GABAA receptor antagonists 
bicuculline and PTX. However, the diverse 
protocol used by Ganguly et al. (2001) for 
culturing of hippocampal neurons might 
lead to different properties of the culture 
in general and GABAergic activity in 
particular. Whatever is the reason for 
this discrepancy (discussed in the section 
3.3.4.2), it is clear that GABAergic 
activity is not an absolute requirement 
of developmental KCC2 increase. This 
was confi rmed later by a study of VIAAT 
knockout mice displaying severe reduction 
of GABAergic and glycinergic activity but 
still normal KCC2 levels (Wojcik et al., 
2006). 
3.2. Upregulation of KCC2 
expression by transcription factor 
Egr4 (II)
Upregulation of KCC2 levels in developing 
neurons implies the activation of gene 
transcription and regulation of promoter 
activity. We aimed to study KCC2 
promoter region and analyze transcription 
factors that might be involved in KCC2 
developmental expression. 
Uvarov et al. (2005) have shown 
previously that genomic fragment 
bearing 1.4 kb sequence upstream of the 
transcription initiation site is suffi cient 
to induce CNS- specifi c pattern of KCC2 
expression. We analyzed 1.4 kb upstream 
promoter and proximal intron-1 regions 
of KCC2 gene from four different species 
and identifi ed ten highly conserved 
transcription factors binding sites (Fig. 1 
in II). We found that among others, KCC2 
promoter bears a consensus binding site 
for neural-specifi c transcription factor 
Egr4 (Crosby et al., 1992). 
Egr proteins are induced by growth 
factors and neuronal activity (O’Donovan 
et al., 1999/4/1). Egr4 expression is 
increased during postnatal development of 
rats (Crosby et al., 1992) and mice (Fig. 
2 in II) synchronously with the course of 
KCC2 upregulation. The predicted Egr4- 
binding site in the KCC2 promoter and 
the data on Egr4 expression let us suggest 
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that Egr4 plays a role in regulation of 
developmental KCC2 expression.  
3.2.1. Egr4 strongly and specifi cally 
activates KCC2 promoter in N2a cells
In order to study the regulation of KCC2 
gene we have generated a series of deletion 
constructs in which a fi refl y luciferase 
reporter was placed under the control of 
different KCC2 gene regulatory regions 
(Fig. 3 in II; table 2).  The construct 
KCC2(-1398/+5445) included 1.4 kb 
upstream promoter, exon-1, intron-2 and 
a part of exon-2. The constructs KCC2(-
1398/+42) and KCC2(-309/+42) included 
1.4 kb or 0.3 kb of upstream promoter 
sequence respectively. The shortest 
KCC2(-180/+42) included only 0.18 kb 
of the promoter and consequently was 
defi cient in Egr4-binding site. 
Human neuroblastoma N2a cells 
do not express Egr4 (unpublished 
observation). After transfection of the 
constructs in N2a cells, we did not see 
any signifi cant difference between the 
basal reporters’ activities regardless 
of the promoter size (Fig. 3 in II). The 
only exception was the longest KCC2(-
1398/+5445) that had lower activity 
presumably due to the unknown repressor 
elements in the proximal part of intron-1 
(Uvarov et al., 2005). However, when the 
reporters were coexpressed in N2a cells 
together with Egr4, there was a robust 
induction of luciferase activity in case of 
the constructs bearing Egr4-binding site. 
Notably, no induction was observed for 
KCC2(-180/+42) lacking Egr4 element. 
The binding consensus for Egr1 is 
very similar to that of Egr4 (Swirnoff and 
Milbrandt, 1995). In order to estimate 
how specifi c Egr4-mediated induction 
of KCC2 promoter is, we compared the 
effect of Egr1 and Egr4 overexpression. 
Importantly, Egr1 failed to induce activity 
of the promoter bearing Egr4 binding site. 
The specifi city of Egr4 action was further 
confi rmed by Egr1/Egr4 competition assay 
(Fig. 3 in II). Electrophoretic mobility 
shift assay (EMSA) has demonstrated the 
effective interaction of Egr4 with Egr4 
binding site in KCC2 promoter (Fig. 4 in 
II). 
Next, we produced two constructs 
with modifi ed Egr4 binding properties. The 
fi rst one was KCC2(-309/+42) construct 
in which Egr4 consensus was mutated 
by the substitution of two crucial nu-
cleotides (KCC2(-309/+42)Egr4mut). EMSA 
confi rmed that this mutation completely 
prevented Egr4 binding to the consensus 
(Fig. 4 in II). Egr4 induction of mutated 
KCC2 promoter was signifi cantly lower 
than the induction of the non-mutated 
one (Fig. 5 in II). Interestingly, 50% of 
Egr4-mediated induction still occurred 
despite the binding failure. It indicates that 
Egr4 overexpression renders both direct 
and indirect effect on KCC2 promoter 
activity. 
The second construct was modifi ed 
KCC2(-180/+42), in which two copies of 
Egr4-binding consensus sequence were 
inserted upstream of short KCC2 promoter 
region lacking Egr4 element. When 
overexpressed in N2a cells together with 
Egr4, this construct showed 4-fold higher 
luciferase activity that the one without the 
insertion (Fig. 5 in II). 
These experiments showed that the 
Egr4-binding site mediates the effect of 
Egr4 on KCC2 promoter activity in N2a 
cells. Our next step was to determine 
whether Egr4 affects KCC2 expression in 
neurons. 
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3.2.2. Egr4 increases KCC2 promoter 
activity in cultured hippocampal and 
cortical neurons
Both Egr4 and KCC2 are expressed in 
developing hippocampus in vivo (Fig. 2 
in II). Similarly, in cultured neurons Egr4 
and KCC2 are upregulated synchronously 
during fi rst two weeks of culture 
development (Fig. 7 in II). 
As a tool to study Egr4-mediated 
KCC2 gene regulation we produced a 
dominant-negative Egr4 isoform (DN-
Egr4) which could bind to Egr4 consensus 
but could not activate gene expression. 
In N2a cells DN-Egr4 was able to inhibit 
up to 70% of Egr4-mediated increase in 
KCC2 promoter activity (Fig. 6 in II). If 
Egr4 is involved in regulation of KCC2 
gene expression in neurons, disruption of 
Egr4 binding should affect KCC2 levels. 
Indeed, when DN-Egr4 was expressed in 
cultured neurons for 48 hours, it notably (by 
25%) decreased endogenous KCC2 levels 
as it was detected by immunostaining with 
KCC2 antibody (Fig. 7 in II). 
DN-Egr4 as well as Egr4-
specifi c siRNA suppressed activity of 
KCC2(-309/+42) construct in div10 but not 
in div5 cultured neurons (Fig. 8 in II). This 
experiment revealed low regulatory activity 
of endogenous Egr4 in young neurons in 
agreement with low Egr4 expression levels 
at early stage of culture development (Fig. 
2 in II). Accordingly, Egr4 overexpression 
increased KCC2(-309/+42) activity by 
100% in div5 neurons but failed to change 
it in div10 cultures. 
Interestingly, in all our experiments 
with cultured neurons, blockade of Egr4 
signalling by means of DN-Egr4 or siRNA 
knock-down leaded to not more than 25-
35% reduction of luciferase activity or 
endogenous KCC2 levels. It is possible 
that the amount of DN-Egr4 or siRNA is 
not enough to prevent endogenous Egr4 
signalling completely. On the other hand, 
overexpression of DN-Egr or siRNA in 
cultured neurons could potentially affect 
transcription of other genes, including 
other transcription factors, and thus part of 
the effect on KCC2 promoter activity might 
be indirect. To evaluate the direct impact 
of endogenous Egr4 on KCC2 promoter, 
we compared the fold increase in KCC2(-
309/+42) and KCC2(-309/+42)Egr4mut 
expression in cultured neurons from div5 
to div10. During this period, the activity of 
KCC2(-309/+42) increased 4.2-fold, while 
the activity of  KCC2(-309/+42)Egr4mut 
increased only 2.7-fold. This indicates that 
the disruption of Egr4 binding to KCC2 
promoter decreases KCC2 expression by 
35%, which is in perfect agreement with 
DN-Egr4 and siRNA data. 
Egr4-defi cient mice were 
characterized by Tourtellotte et al. (1999). 
Despite the mostly neuronal pattern of Egr4 
expression, Egr4-defi cient mice display 
no obvious malfunction in the CNS. On 
the contrary, mice that have impaired 
KCC2 expression exhibit severe CNS 
dysfunction (Hubner et al., 2001). The 
phenotype is milder in animals expressing 
higher KCC2 levels (Tornberg et al., 2005, 
Woo et al., 2002). The mice that retain 
30-40% of normal KCC2 expression 
exhibit no obvious neuronal phenotype 
or behavioral abnormalities (J Tornberg, 
personal communication). Consequently, 
the fact that Egr4 knockout mice exhibit 
no pronounced alteration in CNS 
development can be explained by mild (25-
35%) impact of Egr4 on KCC2 expression. 
Alternatively, the compensation by other 
transcription factors e.g. other Egrs is also 
possible. 
In summary, we characterized the 
1.4 kb mouse KCC2 promoter region and 
identifi ed multiple transcription factor 
binding sites that potentially regulate 
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KCC2 expression. We found that one 
of these factors, Egr4 binds to a specifi c 
sequence in KCC2 promoter and increases 
the activity of mouse KCC2 gene in 
neuronal cells.  
3.3. On the mechanism of develop-
mental KCC2 upregulation (III) 
During recent years, extensive research 
has revealed several stimuli that affect 
KCC2 levels in immature brain and 
might be involved in the regulation of 
KCC2 expression. These are: depolarizing 
GABAergic input acting via [Ca2+]i 
increase (Ganguly et al., 2001), chronic 
overexpression of BDNF (Aguado et al., 
2003) and activity input on developing 
neurons (Kanold and Shatz, 2006, 
Liu et al., 2006; see section 1.6.4.1). 
However, in the studies mentioned above, 
neurons were chronically exposed to the 
stimulation that increases the probability 
of indirect mechanism affecting KCC2 
expression. Moreover, BDNF release, 
synaptic activity and depolarizing GABA 
are interconnected. Indeed, BDNF 
overexpressing mice have higher level of 
spontaneous activity, increased GAD65/67 
expression, and enhanced GABAergic 
synaptogenesis (Aguado et al., 2003); 
depolarizing GABAergic signalling 
induces BDNF expression (Berninger et 
al., 1995, Obrietan et al., 2002); neuronal 
activity is known to regulate BDNF 
release (Lessmann et al., 2003/4). It 
remains unclear whether the mentioned 
extracellular stimuli act separately through 
different signal transduction pathways 
or they work in synergy and trigger the 
same intracellular cascade that eventually 
lead to the activation of KCC2 gene 
transcription.     
In our study we decided to look at 
the matter the other way round, from the 
gene regulation point of view. Keeping in 
mind that Egr4 is involved in regulation of 
KCC2 gene transcription (II) we designed 
a series of experiments aimed to elucidate 
whether growth factors and neuronal 
activity increase KCC2 expression through 
Egr4 induction in immature neurons. 
3.3.1. BDNF increases activity of KCC2 
promoter via MAPK activation and 
Egr4 in cultured neurons
3.3.1.1. BDNF treatment robustly 
increases Egr4 expression in MEK/ERK 
dependent manner
Using mice that carry TrkB receptor with 
mutated PLC or Shc binding site, Rivera 
et al. (2004) demonstrated that in adult 
hippocampus BDNF/TrkB-mediated 
activation of Shc/MAPK pathway induces 
KCC2 upregulation. This suggests that 
in immature neurons the mechanism of 
BDNF/TrkB-mediated KCC2 increase 
may use the same pathway. Importantly, 
although there is no published evidence 
that Egr4 is induced by BDNF, other Egr 
transcription factors were shown to be 
induced by BDNF and NGF in a MAPK/
ERK dependent manner (Calella et al., 
2007, Harada et al., 2001, Roberts et al., 
2006). Here we used immature (div5-6) 
dissociated hippocampal cultures to study 
the effect of BDNF on KCC2 promoter 
activity.
Already 5 minutes after BDNF (50 
ng/ml) application an abrupt increase 
in ERK1/2 and AKT phosphorylation 
was determined by Western blot (Fig. 
1 in III). MEK1/2 inhibitor U0126 
effectively blocked ERK1/2 but not 
AKT phosphorylation. Egr transcription 
factors are induced within 1-2 hours of 
NGF exposure (Crosby et al., 1991). 
Accordantly, a robust increase of Egr4 
mRNA level was observed 1 hour 
after BDNF application (Fig. 1 in III). 
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Importantly, this increase was sensitive to 
MEK1/2 blocker indicating that Egr4 is 
induced via MEK/ERK rather than AKT 
pathway.  
3.3.1.2. BDNF activates KCC2 promoter 
via Egr4-binding site
To determine the activity of KCC2 
promoter upon BDNF stimulation, we 
transfected neurons with KCC2(-309/+42) 
construct. Despite the short (0.3 kb) 
promoter sequence included, in N2a cells 
Egr4 activates KCC2(-309/+42) construct 
to the same extent as other constructs 
bearing longer KCC2 promoter sequences 
(Fig. 3 in II). 
In trasfected neurons, BDNF (50ng/
ml) increased KCC2 promoter activity by 
30%, as indicated by luciferase assay (Fig. 
2 in III). Lower or higher concentrations 
of BDNF (10ng/ml or 200ng/ml) produced 
smaller and more variable effect. BDNF-
induced activation of KCC2 promoter 
was abolished by both tyrosine kinase 
receptor (Trk) blocker K252a and MEK1/2 
inhibitor U0126. This implies that BDNF 
regulation of KCC2 promoter is mediated 
through Trk/MAPK signalling. 
BDNF can induce network activity 
(Lang et al., 2007). To rule out the 
possibility that BDNF-induced network 
activity affected KCC2 regulation we 
perform BDNF treatment in the presence 
of TTX. Pretreatment with TTX did not 
alter BDNF- induced activation of KCC2 
promoter (Fig. 2 in III).
In order to determine whether Egr4 
is involved in mediating BDNF effect 
on KCC2, we compared BDNF-induced 
activation of KCC2(-309/+42) and 
KCC2(-309/+42)Egr4mut constructs. The 
later one is defi cient in Egr4 binding 
because of two point mutations that are 
introduced in Egr4 consensus (Fig. 4 in 
II). Disruption of Egr4 binding completely 
prevented BDNF-induced activation of 
KCC2 promoter indicating that Egr4 is 
an essential player in BDNF signalling 
cascade (Fig. 1 in III).
  
3.3.2. BDNF and neurturin increase 
KCC2 expression in immature cultured 
neurons
DN-EGR4 downregulates endogenous 
KCC2 protein level when overexpressed 
dur ing  d iv8-d iv10  in  immature 
hippocampal cultures (Fig. 7 in II). 
To examine whether BDNF-mediated 
induction of Egr4 affects endogenous 
KCC2 expression, we analyzed KCC2 
protein level in BDNF-treated cultures 
two days after BDNF application. BDNF 
induced a substantial increase in KCC2 
protein levels when it was applied on 
neurons at div4 or div11 (Fig. 3 in III). 
Older cultures failed to upregulate KCC2 
in response to BDNF in agreement with 
the previous data that BDNF reduces 
KCC2 levels in mature neurons (Rivera 
et al., 2002, Rivera et al., 2004, Wake et 
al., 2007). Interestingly, no developmental 
decrease in TrkB expression was observed 
in vitro (Fig. 4 in III) and in vivo (Ivanova 
and Beyer, 2001). This implies that 
developmental change in BDNF effect was 
due to some other reason than receptor 
expression, for instance due to a change in 
TrkB responsiveness (Knusel et al., 1994) 
or a change in predominantly activated 
signal transduction pathway (Huang and 
Reichardt, 2001, Rivera et al., 2004). 
 BDNF failed to induce Egr4 mRNA 
rise in the presence of MEK1/2 inhibitor 
U0126 (Fig. 1 in III).  It emphasizes 
the key role of MAPK activation in 
regulation of KCC2 promoter activity. 
We tested whether another neurotrophic 
factor that is able to induce MAPK 
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phosphorylation, can upregulate KCC2 
expression. Neurturin is the member of 
glial cell line-derived neurotrophic factor 
(GDNF) growth factors family, it operates 
through receptor tyrosine kinase RET/
GFR2 co-receptors and induces MAPK 
phosphorylation in cultured sympathetic 
neurons (Baloh et al., 2000, Kotzbauer et 
al., 1996, Airaksinen and Saarma, 2002). 
Expression of neurturin co-receptors RET 
and GFR2 was found in hippocampal 
neurons throughout culture development 
(Fig. 4 in III). When neurturin (50 ng/ml) 
was applied on cultured neurons it induced 
rapid increase in ERK1/2 phosphorylation 
that was inhibited by U0126 (Fig. 4 in 
III). Similarly to BDNF, 1 hour neurturin 
treatment stimulated significant rise 
in Egr4 mRNA expression. The fold 
induction of Egr4 levels by neurturin 
was much lower than the one caused by 
BDNF (1.6 fold versus 22 fold), however 
it is compatible with Egr4 induction 
found in other studies (Mack et al., 1995). 
Although acting through completely 
different type of tyrosine kinase receptor 
neurturin increased KCC2 expression 
essentially in the same manner as BDNF. 
In hippocampal neurons of different age 
the strongest effect (130% of non-treated 
control) was observed during the second 
week in vitro (Fig. 4 in III).      
In summary, we performed a series 
of in vitro experiments that provide us 
with a model of KCC2 gene regulation 
by extracellular stimuli in immature 
hippocampal neurons. According to this 
model, neurotrophic factors, such as 
BDNF or neurturin, upon binding to their 
receptors induce MAPK phosphorylation 
and EGR4 expression. In turn, Egr4 binds 
to KCC2 promoter and increase KCC2 
levels.
3.3.3. BDNF and neurturin increase 
KCC2 expression when injected in 
neonatal rat hippocampus
We extended our studies in order to see 
whether the model obtained in vitro is 
relevant in vivo. Chronic infusions and 
acute injections in the brain are widely 
used tool for studies of in vivo signalling 
of BDNF (Croll et al., 1994, Croll et 
al., 1998, Messaoudi et al., 1998, Ying 
et al., 2002). BDNF administration in 
hippocampus induces TrkB and ERK1/2 
phosphorylation (Croll et al., 1998, Ying 
et al., 2002). 
We injected 100 ng of BDNF in 
hippocampus of P5 rats. The controlateral 
hippocampus was injected with saline 
solution and used as a control. Three 
days after the injection a series of coronal 
sections was made and KCC2 protein 
levels were analyzed by immunostaining. 
The summarized results for different 
hippocampal layers are presented in Fig. 
5 (study III). The Fig. refl ects minimum, 
average and maximum KCC2 increase 
among all sections that were analyzed. 
For the details of image analysis see 
section 2.4.2. In BDNF- injected 
hippocampus KCC2 protein level was on 
average increased by 15% compared to 
controlateral saline-injected hippocampus. 
The maximal increase varied from 20% to 
40% depending on the hippocampal area.  
We also studied the effect of 
intrahippocampal neurturin injections. In 
contrast to BDNF, no signifi cant increase 
in KCC2 expression was detected after 
administration of 100 ng of neurturin. 
So in subsequent injections we used 
1 g of neurturin. KCC2 levels were 
analyzed three days after the injection by 
immunostaining in a similar way to BDNF 
injection analysis. On average, KCC2 
levels in neurturin-injected hippocampus 
were increased by about 15% compared to 
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contralateral saline- injected hippocampus. 
The maximal increase varied between 30-
80% (Fig. 5 in III).  
Considering that BDNF was shown 
to promote differentiation of GABAergic 
neurons in vitro and in vivo (Aguado et 
al., 2003, Marty et al., 1996), we expected 
to see stronger BDNF effect in the areas 
where interneurons were localized. 
However, there was no signifi cant 
difference between neurotrophic factors 
effect in different layers of hippocampus. 
In vivo data was confi rmed by in vitro 
experiments where similar BDNF-induced 
increase in KCC2 expression was observed 
in both GABAergic and non GABAergic 
cultured neurons (data not shown). 
In summary, BDNF and neurturin 
intrahippocampal administration con-
fi rmed that in immature neurons KCC2 
is upregulated by growth factors and, 
taking into account our in vitro model, 
this upregulation is likely to be direct 
rather the mediated by enhanced neuronal 
maturation. 
3.3.4. Endogenous network activity 
is involved in regulation of KCC2 
expression in vivo
Egr transcription factors are induced by 
neuronal activity and seizures (Beckmann 
and Wilce, 1997, O’Donovan et al., 
1999/4/1). In particular, prolonged Egr4 
expression is induced in hippocampus after 
systemic kainic acid injection (Honkaniemi 
and Sharp, 1999). MAPK activation is 
also regulated by network activity (Adams 
and Sweatt, 2002). Considering that both 
Egr4 and MAPK are involved in KCC2 
gene regulation we aimed to analyze the 
effect of neuronal activity on immature 
KCC2 expression in vivo. For this purpose 
we performed two series of experiments 
in which network activity in hippocampus 
of neonatal rats was either inhibited or 
enhanced. 
3.3.4.1. Tetanus toxin injections
Tetanus toxin prevents the release 
of neurotransmitters by specifi cally 
cleaving the vesicle-associated protein 
synaptobrevin 2 that is necessary for 
presynaptic vesicle exocytosis (Schiavo et 
al., 2000). Single injection of tetanus toxin in 
neonatal rat hippocampus strongly reduces 
the frequency of spontaneous synaptic 
events for several days (Groc et al., 2001, 
Groc et al., 2002). We performed injections 
of 5ng of tetanus toxin in hippocampi of 
P6 rats. Western blot analysis of the area 
around injection site revealed signifi cant 
decrease in KCC2 expression 24 hours 
after tetanus toxin administration (Fig. 7 in 
III). Importantly, the administrated tetanus 
toxin dose was relatively low and did not 
alter the behaviour of the pups. Right after 
the injection, as well as 24 hours later, 
the pups injected with tetanus toxin were 
undistinguishable from the ones injected 
with saline solution.   
3.3.4.2. Kainic acid injections
Kainic acid (KA) is well known for its 
ability to enhance network activity and to 
induce seizures in immature and adult brain 
(Holmes and Thompson, 1988, Holmes, 
1991). We carried out intraperitoneal (ip) 
injection of KA in P6 rats and studied the 
immediate effect of artifi cially enhance 
network activity on KCC2 expression. The 
dose of KA (2 mg/kg) was the lowest one 
that still induced visible seizure symptoms. 
Within 15 minutes after KA administration 
virtually all rats developed scratching, 
rapidly followed by loss of posture control 
and periods of tonic seizures. In rare cases 
rats did not develop seizures within 30 
minutes after KA injection. These rats 
were not taken for further analysis. One 
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hour after the injection rats (also controls) 
received 0.3 l/kg of paraldehyde ip to 
stop the seizures. Already at this stage 
ERK1/2 phosphorylation was enhanced in 
KA injected rats (Fig. 8 in III). In some 
rats brain-penetrant MEK1/2 inhibitor 
SL327 was administrated ip 30 minutes 
before KA injection. Importantly, SL327 
blocked ERK1/2 phosphorylation but 
did not alter seizure development. Real-
time PCR analysis showed that BDNF, 
Egr4 and KCC2 mRNA levels were 
strongly increased 4-6 hours after KA 
injection. Notably, disruption of ERK1/2 
phosphorylation by SL327 fully prevented 
the rise in Egr4 and KCC2 expression.
Taken together these data demonstrate 
that network activity in neonatal 
hippocampus is able to regulate KCC2 
expression. Furthermore, this process 
requires the activation of the MAPK 
cascade with subsequent induction of 
Egr4. Interestingly, animals injected with 
very low doses of KA (0.2 mg/kg) that did 
not have any apparent seizure behavior 
also showed increased KCC2 expression 
levels (data not shown). 
Our results are in line with recent 
work demonstrating activity-dependent 
regulation of KCC2 levels in immature 
brain in vivo (Kanold and Shatz, 2006, 
Liu et al., 2006, Ouardouz and Sastry, 
2005). On the contrary, ours and 
other in vitro studies demonstrate the 
existence of activity- independent KCC2 
expression (study I; Ganguly et al., 2001). 
Additionally, as was discussed in section 
3.1.2, the same disagreement also emerges 
for the studies of the role of depolarizing 
GABA in KCC2 developmental increase. 
These discrepancies indicate that the 
activity- and/or depolarization-dependent 
regulation rides on top of an activity- 
and depolarization-independent, intrinsic 
mechanism. In favour of intrinsic 
mechanism speaks the fact that in all 
documented cases where activity or 
GABA depolarization was blocked, the 
residual level of KCC2 expression was 
still high (Ganguly et al., 2001, Kanold 
and Shatz, 2006, Leitch et al., 2005, Liu 
et al., 2006, Ludwig et al., 2003, Wojcik 
et al., 2006; see also Fig. 7 in III). The 
activity- and depolarization- independent 
KCC2 expression, apart from the intrinsic 
developmental program, may also be 
regulated by constitutive secretion of 
neurotrophic factors (Egan, 2003).
Considering that Egr4 increases KCC2 
expression in MAPK-dependent manner, it 
is tempting to speculate that activation of 
MAPKs by various stimuli will eventually 
result in KCC2 increase. However, this 
idea is clearly oversimplifi ed. In some 
cases when MAPKs are known to be 
activated, KCC2 levels do not rise and even 
fall. For example, KA induced seizures 
increase MAPK phosphorylation (Choi et 
al., 2003, Crespo-Biel et al., 2007, Ferrer 
et al., 2002), BDNF levels (Kornblum et 
al., 1997, Rudge et al., 1998) and Egr4 
(Honkaniemi and Sharp, 1999) in adult 
and neonatal rats (Fig. 8 in III). However, 
after KA administration, KCC2 levels are 
downregulated in adult rats (H. Lahtinen, 
unpublished observation) and upregulated 
in neonatals (Galanopoulou, 2007 and Fig. 
8 in III).  It indicates that the mechanism 
suppressing KCC2 expression interferes 
with Egr4-induced KCC2 gene activation 
and may work through one of the multiply 
additional transcription factors identifi ed 
in the KCC2 promoter (Fig. 1 in II).  
3.4. A novel N-terminal isoform of 
KCC2
The diversity of CCC family members is 
increased by alternative splicing. Several 
isoforms of NKCC1, NKCC2, KCC3 
and KCC4 were identifi ed (discussed in 
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section 1.4.1). N-terminal heterogeneity 
was reported in case of KCC3, including 
two isoforms that are generated via 
utilization of alternative promoters and fi rst 
exons (Mercado et al., 2005). No KCC2 
isoforms were identifi ed before our study; 
however, an analysis of KCC2-defi cient 
mice suggests their existence. Deletion of 
exon-5 (Hubner et al., 2001) or disruption 
of exon-4 (Tornberg et al., 2005) result 
in a complete lack of KCC2 protein. In 
contrast, disruption of exon-1 produces 
mice that on average retain ~5% of KCC2 
protein level (Woo et al., 2002). This 
implies that there is a KCC2 isoform that 
do not include exon-1 and probably utilize 
alternative promoter. Since regulation of 
gene transcription by alternative promoters 
is a common phenomena (Kimura et al., 
2006), we analysed the sequence upstream 
of exon-1 to identify possible promoter 
regions. 
3.4.1. Identifi cation of a new upstream 
exon in the KCC2 gene
CpG islands are associated with 
transcription start sites (Larsen et al., 
1992). Using CpG islands fi nding strategy 
we identifi ed several CpG islands within 
the previously characterized KCC2 
promoter and one CpG island ~7kb 
upstream of it (Fig. 1 in IV). The latter 
one was the candidate for an alternative 
KCC2 promoter. The putative novel 
exon sequence downstream of the new 
promoter was highly conserved among 
several mammalian species (Fig. 2 in IV). 
Using the upstream CpG island sequence 
as a query for BLAST search, we found 
two human expressed sequence tag (EST) 
clones in which novel exon-1 (now termed 
exon-1a) was spliced directly to exon-2 
and subsequent KCC2 exons. However, 
no similar mouse ESTs were present in the 
database. To address whether the transcript 
of the novel isoform is expressed in mice, 
we analyzed adult mouse brain samples by 
RT-PCR. PCR with primers for exon-1a 
and exon-2 yielded a product of expected 
size; sequencing of the PCR product further 
supported a direct splicing of exon-1a to 
exon-2 (Fig. 1 in IV). Full-length cDNA 
for the KCC2 isoform containing exon-1a 
(KCC2a) was obtained by nested PCR. 
Sequencing of the PCR product confi rmed 
that KCC2a differs from the previously 
known KCC2 (now termed KCC2b) only 
by a presence of exon-1a instead of exon-
1b; all other exons are identical.  
When analyzing sequence alignment, 
we found that amino acid residues 3-12 in 
the exon-1a are highly conserved among 
several species (Fig. 2 in IV). These 
residues comprise a putative SPAK-OSR1 
binding site. Similar SPAK-OSR1 binding 
motifs are found in N-terminal parts 
of NKCC1, NKCC2, KCC1, KCC3a, 
KCC3b, and KCC4 but not KCC2b 
(Piechotta et al., 2002). SPAK and OSR1 
kinases are implicated in kinetic regulation 
of cotransporters’ activity (discussed in 
section 1.4.2). Thus, KCC2a possess a 
distinct N-terminus that includes SPAK-
OSR1 binding motif absent from KCC2b. 
It implies that KCC2a and KCC2b might 
be differently regulated in brain areas 
where SPAK/OSR expression is found, 
e.g. brainstem. 
3.4.2. Characterization of KCC2a 
expression in nervous system
Since the two KCC2 isoforms are driven 
by different promoters it is possible that 
KCC2a and KCC2b expression patterns 
are different. Previous studies used PCR 
primers, in situ probes, or antibodies that 
detect both KCC2 isoforms or KCC2b 
only (see section 1.6). In order to address 
KCC2a expression specifi cally, we 
performed RNA protection assay (RPA) 
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and quantitative real-time PCR (RT PCR) 
with KCC2a and KCC2b specifi c primers. 
We found that KCC2a, similarly to KCC2b 
is expressed only in neuronal tissues 
(fi gures 3 and 4 in IV). At E17 KCC2a 
accounted for almost half of total KCC2 
levels whereas at P14 KCC2a expression 
was three to six times lower than KCC2b 
expression (Fig. 3 in IV). The data on 
comparative KCC2a/KCC2b expression 
was indirectly confi rmed by the fi nding 
that KCC2a promoter is twice less active 
in cortical neurons than the previously 
studied KCC2b promoter (Fig. 5 in IV). 
We found that the developmental KCC2 
upregulation occurs because of dramatic 
increase in KCC2b levels. On the contrary, 
KCC2a remained relatively stable during 
development (Fig. 4 in IV). Although 
the data on KCC2a expression pattern 
gathered in this study is quite preliminary, 
it implies that the novel isoform may play 
an important role in embryonic neurons of 
spinal cord and brainstem where KCC2a/
KCC2b ratio is rather high. However, more 
detailed analysis of KCC2a expression, 
including immunostaining, is required 
to detect whether high levels of KCC2a 
are present also at some other specifi c 
locations in the brain.
   
3.4.3. Functionality of KCC2a
86Rb fl ux assay allows direct measurement 
of the cotransporter activity (Gillen and 
Forbush, 1999, Payne, 1997). We studied 
functional 86Rb uptake in HEK293 cells 
transiently transfected with KCC2a 
or KCC2b expression vectors. Upon 
transfection with any of two isoforms, 86Rb 
uptake increased about 2.5-fold compared 
to non-transfected, control cells (Fig. 6 
in IV). K-Cl cotransporters are sensitive 
to “loop” diuretics (e.g., furosemide and 
bumetanide) and are activated by the 
thiol alkylating reagent N-ethylmaleimide 
(NEM) (Gamba, 2005). In the case of 
KCC2a, pretreatment with furosemide 
(2 mM) reduced 86Rb uptake to non-
transfected control level. On the contrary, 
pretreatment with NEM (1 mM) increased 
the uptake 2.2 fold (Fig. 6 in IV). 
Among all KCCs, KCC2 is unique in 
mediating constitutive K-Cl cotransport 
because of its distinct C-terminal domain 
(Mercado et al., 2006). In this study we 
show that two KCC2 isoforms share the 
same C-terminal part. Accordingly, both 
of them can mediate isotonic 86Rb uptake 
that is comparable to KCC2-mediated 86Rb 
infl ux reported in previous studies (Payne, 
1997).
3.4.4. KCC2b-defi cient mice retain 
KCC2a mRNA expression
Finally, we analyzed the expression of 
KCC2a isoform in transgenic mice with 
targeted disruption of exon-1b (KCC2b-/-; 
Woo et al., 2002). These mice retain intact 
exon-1a and 5-8% of normal KCC2 protein 
levels (at P10-P12). We suggested that the 
residual KCC2 expression and postnatal 
survival of KCC2b defi cient mice is 
attributable to KCC2a isoform. Analysis by 
RT-PCR confi rmed that no KCC2b mRNA 
was expressed in KCC2b-/- brain, while 
KCC2a mRNA was present (Fig. 7 in IV). 
Accordingly, the proportion of KCC2b to 
KCC2a mRNA in KCC2b+/- brain was 
50% of that in the wild-type mouse brain. 
KCC2a mRNA expression remained 
unchanged between the phenotypes (Fig. 
7 in IV). 
KCC2b defi cient mice do not die 
at birth as full KCC2 knockout mice 
(Hubner et al., 2001, Woo et al., 2002). 
Our data suggest that KCC2a expression 
in KCC2b defi cient mice is enough 
to maintain basic inhibitory functions 
required for survival. However, KCC2b 
defi cient mice eventually die by the end 
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of second postnatal week due to repetitive 
spontaneous seizures. Presumably, KCC2a 
levels in the cortex are too low to maintain 
higher Cl- extrusion capacity required 
for hyperpolarizing inhibition in mature 
cortical neurons. Indeed, cortical neurons 
isolated from KCC2b defi cient mice show 
impaired Cl- extrusion (Zhu et al., 2005).  
In summary, we have identifi ed a novel 
KCC2 isoform with distinct N-terminus 
generated by the usage of the alternative 
promoter and fi rst exon. N-terminal part 
of KCC2a but not of previously known 
KCC2b possesses putative SPAK/OSR 
binding motif. KCC2a encode a protein 
with isotonic K-Cl cotransport activity 
that is similar to the activity of KCC2b 
isoform. KCC2a mRNA is expressed in 
the brain and contributes 20-50% of total 
KCC2 mRNA in neonatal brainstem and 
spinal cord. During development KCC2a 
mRNA expression remains stable in 
contrast to KCC2b mRNA that is strongly 
upregulated. We also show that the mice 
with targeted disruption of exon-1b have 
intact KCC2a mRNA levels and we 
speculate that KCC2a ensures survival of 
these mice after birth in contrast to full 
KCC2 knockout.      
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4. CONCLUSIONS
The main fi ndings of this thesis are:
1. KCC2 expression is upregulated during development of hippocampal neurons in 
vitro. This upregulation does not require synaptic activity.
2. KCC2 promoter contains multiple putative transcription factor binding sites, one of 
which, Egr4, is able to enhance KCC2 transcription in cultured neurons.
3. In developing neurons in vitro, KCC2 expression is increased by BDNF- or neurturin. 
Growth factor -dependent KCC2 increase requires MAPK activation and Egr4 
binding to KCC2 promoter. BDNF and neurturin also upregulate KCC2 protein 
levels in vivo, when injected in hippocampus of neonatal rats.
4. Neuronal activity affects KCC2 mRNA expression in neonatal rat hippocampus in 
vivo. A period of KA-induced seizures increases Egr4 and KCC2 mRNA levels in 
a MAPK-dependent manner. Reduction of spontaneous activity by tetanus toxin 
decreases KCC2 protein expression.  
5. KCC2 gene produces at least two isoforms different in their promoter region 
and alternatively spliced fi rst exon. Similarly to the previously known KCC2b 
isoform, the novel KCC2a isoform is expressed in the CNS. However, KCC2a is 
not upregulated during postnatal rodent brain development. KCC2a accounts for 
a signifi cant part of total KCC2 levels in neonatal brainstem and spinal cord and 
prolongs survival of KCC2b defi cient mice for two weeks in comparison to the mice 
lacking both KCC2 isoforms. 
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